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ABSTRACT

Peptoids are a class of peptidomimetic polymers, which have attracted much
attention over the years. Due to their structural similarity to peptides, this group of
polymers affords good biocompatibility making them of interest for biomedical
applications.

This

dissertation

is

largely

about

the

design,

synthesis,

and

characterization of cationic polypeptoids for biological applications, particularly nonviral
gene delivery. The dissertation will also cover the development, characterization, and
polymerization behavior of a new, air stable N-thiocarboxyanhydride (NTA) monomer.
Introducing functionality, such as small biomolecules and organic compounds
can provide distinctive properties to the polymers. Chapter 1 introduces gene therapy
and concepts pertinent to the topic. Cell transfection and methods and techniques used
to carry out the process are described along with their associated advantages and
disadvantages.
Chapter 2 provides an overview on the fundamental aspects of polypeptoids as
well as previous and recent developments in synthetic strategies, post-polymerization
modification, and biological applications in various fields.
Chapter 3 describes the development of cationic polypeptoids by traditional
polymerization

and

post-functionalization

methods.

Analogue’s

gene

delivery

capabilities demonstrated in this chapter establish the potential of this peptidomimetic
class of polymers as carriers for gene delivery. Work presented in chapter 4
emphasizes more on the application attribute of cationic polypeptoids via delivery of
TNF- siRNA for effective knockdown of systemic inflammation.

viii

Based upon studies done in chapters 3-4, chapter 5 explores a new direction of
varying polymer architectures. The effect of architecture on the nonviral gene delivery of
diblock copolypeptoids in serum was assessed.
Research foci of Chapter 6 pertains to the development, characterization, and
polymerization of new, N-Allyl N-thiocarboxyanhydride (Al-NTA), the mercapto analog of
the corresponding NCA. The NTA exhibited enhanced moisture-stability but reduced
polymerization activities relative to the NCA analogs.
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CHAPTER 1: INTRODUCTION TO GENE THERAPY
1.1 Purpose
This chapter will introduce gene therapy and provide an overview of the concepts
relevant to the topic and problems in the field, particularly with cell transfection. Aspects
essential to the cell transfection process including methods used, carrier types, and
associated advantages and disadvantages will be discussed. Recent developments in
the design and synthesis of carriers for gene delivery will also be mentioned.
1.2 Overview of Gene Therapy
In the late 20th century, the concept of gene therapy (GT) research was first
introduced by pioneers Theodore Friedmann and Richard Roblin in a landmark paper.1
Initially the primary focus of gene therapy was geared towards correcting inherited
genetic disorders. However, as new and rare diseases began to appear, gene therapy
becomes increasingly relevant. GT is typically achieved by two technologies, germline
and somatic. Whereas germline GT offers a means to correction or the permanent
elimination of a genetic abnormality via direct manipulation of germline cells (eggs and
sperm), somatic GT involves the insertion of genes into the nonreproductive diploid cells
of an individual, thus providing an indirect approach for addressing genetic
malfunctions. The major difference among the two methods is that unlike with germline
GT, results from somatic therapy are restricted to the patient and are not passed on to
their offspring. Though potentially useful, germline gene therapy is considered unethical
and has never actually been performed on humans. For this reason, somatic gene
therapy is more commonly practiced on individuals with fewer associated risks than the
former method.

Within somatic gene therapy, various types of treatment for different disorders
are readily available. To access the efficacy of gene therapy under different conditions,
gene delivery experiments were conducted under ex vivo, in situ, and in vivo conditions.
Under ex vivo conditions, experiments and measurements are performed outside of the
organism. The ex vivo procedures allow the manipulation of cells and tissues to be
carried out in an uncontrolled fashion. Fluctuations in cell culture conditions externally
(temperature, pH, etc.) are a major disadvantage of ex vivo delivery that can possibly
lead to disrupted host cell division. In vitro delivery is the commonly used type of ex vivo
experiment where the measurement of gene expression is observed using cells of a
specific cell line. In the course of in situ experiments, a specific gene or protein is
studied in its natural context. This method is advantageous in that a consistent
environment for observing is maintained by minimizing the chances of disruption in
original conditions. The in vivo delivery method is characterized by the use of a live
animal to study behavior or how different genes can affect the entire organism. During
experiments the transference of genetic material to cells takes place while still inside of
the patient or subject’s body. In vivo delivery is most relevant to assess the efficacy of
gene therapy since ultimately the delivery has to occur in an organism. All levels of
gene therapy experiments are based on the process of cell transfection as shown in
Figure 1.1.
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Figure 1.1. Nonviral cell transfection process.
(Photo by Unknown Author on https://cylcodextrinvectorsforgenetherap.wikispaces.com/.
Retrieved from https://cylcodextrinvectorsforgenetherap.wikispaces.com/. Used under the
Creative Commons License Attribution-ShareAlike 3.0 Unported CC BY-SA).

1.3 Cell Transfection Process and Techniques Used
Significant progress has been made in gene therapy over the years including the
successful treatment of congenital disease, adenoside deaminase severe combined
immunodeficiency (ADA-SCID).2,3 However, the safe and efficient delivery of
intracellular material remains a subject of intensive investigation and great concern.
Studies indicate that the gene transfection efficacy to be dependent on multiple factors
such as the binding of nucleic acid with transport carrier (complexation), cell recognition,
uptake of components by the cell, and the release of genetic material (decomplexation)
at targeted sites. Moreover, in the case of treating conditions requiring cell or tissue

3

specificity (i.e. cancer), incorporation of cell-speciﬁc ligands in the carrier design can
overcome the challenge of selectivity. Defined by the deliberate act of introducing
nucleic acid into eukaryotic cells, cell transfection relies on the proper genome insertion
and expression of genetic material. Depending on the nucleic acid being delivered the
process of transfection may take place in either the cytosol (for RNA) or nuclear
domains (for DNA). Classified into three categories (biological, physical, and chemical),
available methods for gene delivery offer a broad range of options for the transport of
nucleic acids to subcellular regions in cells.4 Virus-mediated transfection is the only
biological method available for treatment. Considered the most effective for gene
delivery due to their biological occurrence, viral carriers easily avoid both extracellular
and intracellular barriers presented in vivo which enable their excellent gene delivery
performance. However, limited cargo loading and the tendency of viruses to
simultaneously mutate resulting in cytotoxicity and undesired immune response have
restricted their clinical applicability. Physical approaches for transfection include
electroporation, gene gun, sonoporation, and magnetofection. Advantages of these
methods are the direct transfer of nucleic acids into the cytoplasm or nucleus via
noninvasive procedures for transfection. The inability to access internal organs,
expensive instrumentation, and sample damage are the major drawbacks that limit the
practical use of these methods. In chemical methods for transfection, the transfer of
nucleic acids into the cytoplasm or nucleus is achieved by means of a foreign carrier
(i.e. biomolecules, lipids, polymers, etc). Among all the approaches, non-viral delivery
methods have shown to be very promising due to the inherent synthetic versatility and
tunability.
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1.4. Nonviral Cell Transfection Carriers and Associated Milestones
Gene carriers for cell transfection have included the use of non-viral based
materials such as lipids, peptides, and polymers.5-7 Each class of carrier materials has
presented advantages useful for gene delivery. As one of the most extensively
investigated and commonly used nonviral gene delivery method, cationic lipids have the
ability to complex with negatively charged nucleic acid to induce cellular uptake and
endosomal escape. However, low transfection efficiency, toxicity, colloidal instability,
and short duration of gene expression are major hurdles that limit practical use of
lipoplex-mediated transfection. Due to their high net positive charge, a systemic
elimination of cationic lipids occurs upon formation of larger aggregates via their
interactions with the negatively charged serum molecules or cellular components. This
drawback of fast clearance from circulation limits their utility in gene delivery to cells
located beyond vascular endothelial cells.28 Polypeptides have been widely used as
materials for gene delivery based on their innate ability to adopt ordered conformations
(-helices and -sheets). This unique characteristic can aid with the effective
complexation of DNA.36 Though highly compatible and effective, issues such as
cytotoxicity and proteolytic instability restrict their use in biomedical applications.
Strategies such as retroinversion of cell penetrating peptides (CPPs) sequence and/or
the conversion to -peptides have been investigated in order to overcome these
challenges.8 Unfortunately, this development only led to increased cell toxicity. In
comparison to synthetic carriers, viral vectors offer excellent transfection efficiency.9,11
However, viral degradation, repeated dosage, and the risk of attacking non-diseased
cells limit the use of viruses as gene delivery vehicles.9-12 Researchers have since then
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navigated towards the conjugation of synthetic oligomers and polymers with bioactive
moieties and the synthesis of novel biomimetic polymers in hope to combine the
synthetic versatility with biological activities required for efficient gene transfection.
Cationic polymers have been widely investigated for gene transfection owing to their
ability to condense with and introduce genetic materials into cells.12 Their success is
credited to high density of charged groups and tunability of lipophilicity-andhydrophilicity balance (HLB). Poly(lysine)12, Poly(ethylenimine) (PEI)13,14, chitosan15,
and Poly(amido amine) (PAMAM)16 are amongst commonly used cationic polymers in
DNA complexation and cell transfection (Figure 1.2). Polypeptoids, a class of
peptidomimetic polymers, have emerged in cell biology as potential gene delivery
agents.26 Their structural tunability and resistant to proteolytic degradation17 make
polypeptoids attractive for biomedical applications.26

6

Figure 1.2. Chemical structures of commonly studied synthetic cationic polymers in
gene delivery. (Reprinted with permission from reference38, copyright (2017) Elsevier).
(1) Poly(L-lysine), (2) diethyl aminoethyl methacrylate, (3) linear PEI, (4) branched PEI,
(5)
poly(dimethylaminoethyl
methacrylate),
(6)
poly(L-glutamic
acid),
(7)
polyphosphates, (8) polyphosphoramidates, (9) chitosan, (10) poly (DMAE)phosphazene, (11) linear poly(-amino ester)s, (12) polyaminoamine dendrimer.
1.5 Cell Transfection with Amine-based Polymers and Polyammoniums.
Research efforts have focused heavily on the use of amine-containing polymers
as nonviral delivery systems for the efficient packing and transport of genetic materials.
Ability to condense nucleic acids to form polyplexes for protection and transport of
genetic materials into cells has made them practical for biomedical and therapeutic
applications. However, correlation between the transfection efficiency and cytotoxicity of
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amine containing cationic polymers are unsatisfactory.18,19 This has been attributed to
the cytotoxic nature of all cationic polymers above the certain concentration threshold.
In a study by Wetering et al. homopolymers and copolymers based on
dimethylaminoethyl methacrylate (DMAMEM) with methyl methacrylate (MMA),
ethoxytriethylene glycol methacrylate (triEGMA), or N-vinyl-pyrrolidone (NVP) having
low molecular weights were synthesized and investigated as transfection agents for
pCMV-LacZ and evaluated for their cytotoxicity. Polymer/plasmid polyplexes of the
homopolymers and copolymers were tested with different cell lines for their transfection
efficiency. DMAMEM copolymers with hydrophilic NVP and amphiphilic triEGMA were
found to have the same transfection efficiency and cytotoxicity as the homopolymer with
similar molecular weight.20 By contrast, copolymers containing hydrophobic (MMA)
yielded low transfection efficiency as a result of low cell viability suggesting that
transfection efficiency and cytotoxicity is greatly dependent on polymer composition. A
gene-delivery system with high stability and low cytotoxicity, based on the encapsulation
of epsilon-polylysinegrafted-succinic acid-grafted--cyclodextrin-LMW PEI (PPC) and
adamantane-functionalized poly-(ethylene glycol) was constructed and explored for its
transfection capability by P. Lv et al. (Scheme 1.1).25 Using HEK293 cells, in vitro
studies of the polyplexes in 10% serum-supplemented medium using luciferase marker
gene revealed comparable transfection efficiencies for the commercial standard PEI25000 and PEG functionalized PPC. Unmodified PPC carriers produced lower
transfection and higher cytotoxicity presumably due to the formation of internalized large
aggregates.
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Scheme 1.1. Synthesis of adamantine-PEG modified PPC. (Reprinted with permission
from reference25, copyright (2017) Elsevier).
Efforts to improve nuclear targeting and haemocompatibility of dextran-based
carriers during gene delivery via the incorporation of oligoamines have been
successfully put forth by Thomas and coworkers.27 In a study the cationic dextran
derivative, Dex-P, was designed by means of combining the innate cationic and nuclear
targeting properties of protamine with the biodegradable polysaccharide for a
haemocompatible gene carrier. Assessment of the system’s ability to facilitate efficient
transfection in HepG2 cells resulted in lower levels of gene expression in comparison to
bPEI25, under serum-free and containing conditions. The highest transfection of DexP/DNA complexes was achieved at a low weight ratio (2:1). Increase in polymer/DNA
w/w ratio resulted in decreased transfection efficiencies of the nanoplexes. While
transfection efficiency in serum free medium was hampered by increasing polymer/DNA
weight ratios (2-7) of polymer to DNA due to the shielding effect of polymer, efficiencies
in the presence of serum were enhanced demonstrating the haemocompatibility of the
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cationized dextran carrier. Depiction of nanoplexes in the nuclear region of cells by
fluorescence microscopy confirmed that target specificity was introduced to the natural
biocompatible polymer (Dextran) by incorporating protamine.27
Although very effective in the condensation of DNA for their size, oligomer-based
amines are unable to carry out effective transfection alone due to the absence of
cationic surface charge following DNA binding.21 Polymers of larger molecular weight
that are capable of sustaining net positive charge upon condensation must be used for
effective transfection. However, the increase of molecular weight can result in enhanced
cytotoxicity.22 To address this issue, polymers that can degrade into low molecular
species have been developed. For example, H.C. Kang et al. evaluated a series of
reducible polycations (RPCs) synthesized from branched polyethyIeneimine (bPEI) via
thiolation and oxidation for their influence on reducing cytotoxicity and enhancing
transfection characteristics in comparison to high molecular weight bPEI (HMW bPEI;
25 kDa). Branched PEIs with varied molecular weights (Mw: 0.8 kDa and Mw: 750 kDa)
were used with 2-iminothiolane to prepare four samples of low molecular reducible
polycations ([1] 80.3 kDa, [2] 52.7 kDa, [3] 6.3 kDa, and [4] 5.7 kDa).23 Amongst several
factors, the reducible LMW bPEI polymers were mainly anticipated to reduce protoninduced cytotoxicity and effectively condense DNA at relative low charge ratios. RPCsbPEI0.8 1 and 2 showed higher cytotoxicities than bPEI25kDa in HEK293 cells due to
higher molecular weight. However, RPCs 1 and 2 produced an IC50 8-9 fold higher than
bPEI25kDa. In contrast, RPCs 3 and 4 generated cytotoxicities 14-19 times lower than
bPEI25. All four polycations demonstrated significantly lowered toxicities in MCF7 cells
than bPEI25 (9-15 fold) confirming the hypotheses that low molecular weight carriers
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reduce the tendency to interact with intracellular and extracellular components, thus
resulting in reduced cytotoxicities.
The condensation and transfection of DNA using cationic peptoids was first
explored by Murphy and coworkers (Table 1.1).24 A library of oligomeric analogues with
varying hydrophobicity, sequence, and main-chain length were synthesized and
evaluated for their biological activity against commercial lipid vectors.24 A 12-mer
composed of a repeating triple motif (cationic-hydrophobic-hydrophobic) was the only
polyammonium found to demonstrate enhanced DNA complexation and transfection in
comparison with cationized homopolymers of higher molecular weight. Additionally,
oligomeric peptoid carriers produced higher transfection efficiencies than the
commercial lipid vector (DMPE). Under both serum-free and serum containing
conditions the nonviral gene delivery of the cationic peptoids were observed to be
higher than DMPE. Unlike some cationic systems (e.g., lipids, PLL, etc.) that require
catalytic amounts of chloroquine for assistance with lysosomal degradation, peptoid’s
ability to initiate endosomal release on its own was also elucidated.24

Table 1.1. N-substituted glycine side chain and designators.24

11

1.6 Current Challenges in the Design of Synthetic Carriers for Nonviral Cell
Transfection
The implementation of gene therapy to treat rare genetic diseases and disorders
require the continuous innovations in the development of effective gene delivery
carriers. Several aspects related to nonviral gene carrier materials need to be properly
addressed to ensure their optimal performance. Presently, nonviral vectors encounter
various hurdles during in vitro and in vivo delivery (i.e. cell type-dependent transfection
efficiency, post-transfection clearance, cytotoxicity, target delivery) that result in
diminished gene transfection.28,29 One major obstacle for most of the existing nonviral
gene delivery vectors is the instability of positively charged complexes caused by
plasma proteins. To reduce non-specific interaction with plasma components, strategies
such as PEGylation30-32 have been used. Poly(ethyleneglycol) (PEG) has often been
used to shield polyplexes. Because of its hydrophilic and flexible nature, PEG increases
steric stability, prevents nonspecific interactions with surrounding molecules, and
eventually reduces toxicity. The second major obstacle for carriers is the endosomal
entrapment of nonviral vectors following endocytosis. To help facilitate endosomal
escape of nonviral vectors, agents such as chloroquine33,34 or conjugation with
fusogenic peptides35 have been employed. Though chloroquine itself lacks the ability of
condensing DNA, chloroquine and its derivatives are known to accumulate in
endosomal compartment, buffer endosome acidification, and result in endosome
destabilization through a so called “proton sponge” effect. The buffer capacity and
electrostatic interaction of charged fusogenic additives with the endosomal membrane
mediate the destabilization of endosomes. Together these strategies have alleviated
some of the issues associated with the nonviral delivery system and hence attribute the
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advancement of gene therapy as a whole. Our recent effort in developing cationic
polypeptoids as synthetic carriers for gene transfection will be discussed in chapters 35.
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CHAPTER 2: OVERVIEW OF POLYPEPTOIDS (POIs)
2.1 Background on Polypeptoids
Since their discovery during the 1980’s, polymeric N-substituted glycines a.k.a
polypeptoids (POIs) have become increasingly investigated in many scientific fields.1
This special class of psuedo-peptidic polymers bear substituents directly on the nitrogen
atom present in the backbone. In contrast to peptides, the presence of alkyl groups on
nitrogen prevent peptoids from participating in extensive hydrogen bonding as displayed
in Figure 2.1.7 Additionally, this N-substitution affords peptoids with unique
physiochemical properties. Enhanced proteolytic stability against enzymatic degradation
by these systems is a prime example.2,3 Polypeptoids are known for their biocompatible
and biodegradable properties which make them potential candidates for a variety of
biomedical and biotechnological applications such as smart-coatings, drug delivery, and
bioseperation.4-6 In the rest of the discussion, polypeptoids will be used to referred to
poly(-peptoids).

Figure 2.1. Chemical structure of polypeptide, polypeptoids and other peptidomimetic
polymers (reproduced from reference 7).
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2.2 Significance of POIs as Peptidomimetic Materials: Benefits over Peptides
Peptides have been extensively investigated to gain understanding of their
sequence-conformation relationship and enzymatic degradation behavior towards
biomedical applications.8 In spite their proven usefulness as biocompatible and
biodegradable materials, peptide based therapeutics often suffer from poor oral
bioavailability and short half-life in the body and can induce an immune response.9
Research in peptidomimetics has gained attraction with the goal to improve the
physical-chemical-biological properties of peptides. Strategies such as incorporating
one or more peptoid residues to generate peptide-peptoid hybrids (or “peptomers”) have
been proposed and investigated.53
Despite the difference in chemical composition of polypeptoids, their structural
similarity to polypeptides has afforded them opportunities in diagnostics, drug-discovery,
material science, and fundamental studies involving bio-applications.5,8 Classified as
peptide regioisomers, conformations and properties of POIs are dictated mainly by their
appendant side chain (e.g., electronic, sterics).6-11 Such characteristics are attributed to
the absence of a stereogenic center and a lack in hydrogen bonding in polypeptoids.
These features are also responsible for peptoids thermal processability.12 Depending on
the N-substituent structure, solubility of polypeptoids in water can be systematically
controlled (Figure 2.2).13
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Figure 2.2. Different water solubility of the polypeptoid bearing different N-substituents.
2.3. Synthesis of N-carboxyanhydride (NCA) Monomers and Polypeptoids
2.3.1 Synthesis of N-substituted NCAs
A series of N-substituted N-carboxyanhydrides (R-NCAs) monomers bearing
different N-substituents (e.g., ethyl, allyl, propargyl, decyl, etc.) have been developed by
means of two general synthetic methods. Starting with glyoxylic acid and the respective
primary amine, N-substituted glycine precursors were obtained from reductive amination
reaction.14-16 Alkoxycarbonyl protected N-substituted glycine was then obtained via the
reaction of di-tert-butyl dicarbonate and the N-substituted glycine precursor (Scheme
2.1).17 Lastly, cyclization of alkoxycarbonyl protected N-substituted glycine with an
acylating agent (i.e., PCl3, PBr3, and SOCl2) afforded the desired R-NCAs. Due to their
high sensitivity to moisture, purification and storage of R-NCA monomers under inert
atmosphere is necessary. In the case of N-allyl and N-ethyl NCAs that remain as an oil
at room temperature, a trace mount of moisture can easily initiate spontaneous
polymerization.

19

Scheme 2.1. Synthetic routes of R-NCA monomer (copied from reference 17).

2.3.2 Synthesis of polypeptoids by polymerization of R-NCA
Solid-phase submonomer method is commonly used to prepare oligomeric
peptoids with well-defined monomer sequences. As a result of two chemical steps
(acylation and displacement) this synthetic route allows a variety of commercial
available primary amine sources to be used for peptoid synthesis. Sequence-defined
structures can be synthesized in this manner. This synthetic advantage has also
enabled scientists to gain understanding about monomer sequence in relation to overall
polymer conformation and polymer self-assembly in solution or solid state.18-20 Peptoid
therapeutics research has also advanced significantly due to sequence control afforded
by this synthetic strategy.21 Control of the monomer sequence is the key advantage of
submonomer synthesis. However, the solid-phase submonomer method has some
limitations. The lengthy timeframe it takes to synthesize peptoids via solid-phase
submonomer approach has been reported by Zuckerman et al.22 The submonomer
method can only afford short chain polypeptoids (typically less than 30 residues) with
relative low molecular weight polymers.
Polymerization strategies are often pursued to access polypeptoids with high
molecular weight. The ring-opening polymerization of R-NCAs has been accomplished
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with several initiation systems. Various primary amines, organobases (i.e., DBU, TMG),
and N-heterocyclic carbenes have been used as initiators in the ROP of R-NCAs to
produce polypeptoids having different N-substituent structure, molecular architecture
(e.g., cyclic or linear) and controlled molecular weights. Recently, Chan et al. also
demonstrated the use of alcohols as initiators for ROP of NCAs.23 Peng et al. have used
rare earth borohydrides as initiators for the ROP of NCAs yielding α-hydroxy-ωaminotelechelic polypeptoids. 24,25
Primary amines are the most widely used initiators for polypeptoid synthesis due
to their convenience for post-functionalization and the variety of structures that are
readily available from commercial sources (Scheme 2.2).26 Benzylamine-initiated ROP
of N-methyl NCA (Me-NCA) was shown to proceed in a controlled manner without chain
transfer or termination events after more than 10 iterative polymerization steps.
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The

produced polysarcosine (PNMG) exhibited narrow Poisson distribution (PDI<1.1-1.3)
and controllable molecular weight by simply changing the initial monomer to initiator
feed ratios. The living chain end of PNMG was further supported by the chain extension
experiment with different monomers (e.g., Et-NCA, Pr-NCA, Bu-NCA and Pe-NCA). The
living polymerization character of other monomers (e.g., Et-NCA, Pr-NCA, Bu-NCA) was
also reported.48-49
Xuan et al. reported the synthesis of a triblock copolypeptoid via the sequential
ROP of different R-NCA monomers starting from benzylamine initiator. The ABC triblock
copolypeptoids contained hydrophobic, hydrophilic, and thermoresponsive segments.4
Upon heating, it was observed that the triblock copolypeptoid systems formed free
standing gels with narrow sol-to-gel transition windows and that the gels could be
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injected through a 24 gauge needle without breaking apart. Likewise using benzylamine
initiator, Li et al. recently reported the synthesis of core-crosslinked micelles composed
of poly(N-ethyl glycine), poly(N-propargyl glycine), and poly(N-decyl glycine).27
Crosslinking was achieved via CuAAC (vide supra) using a disulfide crosslinker species
which could be degraded using glutathione. The loading and gradual release of
doxorubicin, a common anti-cancer drug was also demonstrated.

Scheme 2.2. Primary amine-initiated ring-opening polymerization of NCA (via NAM).

2.3.3 Synthesis of polypeptoids via the normal amine mechanism (NAM)
From a mechanistic view point, primary amine-initiated ROP of R-NCAs
proceeds by the normal amine (NAM) mechanism (Scheme 2.2). Because R-NCA
monomers lack the labile N-H proton that presents in the conventional amino acid
derived NCAs, ROP of R-NCA by the normal amine mechanism occurs with minimal
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side reactions that often plague the ROP of NCAs bearing N-H protons (e.g.,
deprotonation of N-H, isocyanate formation). The initiation step of the NAM is a
nucleophilic ring-opening addition of primary amine at the C5 carbonyl of R-NCA. The
following proton transfer generates a terminal carbamic acid. Due the thermal instability
of the carbamic acid, it subsequently undergoes a decarboxylation step to form a new
secondary amine species to complete the initiation step. The newly formed secondary
amine reacts with another R-NCA monomer in a similar manner until all monomers are
consumed, which constitutes the propagation event (Scheme 2.2). 28
2.4 Functional Polypeptoids
In order to tailor the property of polypeptoids for different applications, additional
synthetic strategies must be developed to further diversify the N-substituent structure in
polypeptoids. To date, two approaches to synthesize functional polypeptoids exist: the
post-polymerization modification method and polymerization of functional R-NCA
monomer. The post-polymerization have several advantages. First of all, a variety of
different functional groups can be introduced to the polypeptoid backbone by choosing
efficient conjugation chemical reactions (e.g., various “click” chemistry). 29,30 Secondary,
the sidechain functionalized polypeptoids will have the same molecular weight and
molecular weight distribution as the parent polymers. For the functional NCA monomer
route, NCA bearing functional N-substituent is polymerized via ROP to afford functional
polypeptoid.31,32 However, functional R-NCA monomer synthesis is a tedious and nontrivial task. It entails the design of a new synthetic route, optimization of purification,
polymerization conditions, and the careful handling of R-NCAs that may have poor
stability. With a well-established synthetic platform, the post-polymerization route offers
an efficient and easy for way to obtain functional polypeptoids.
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2.5 Preparation of Functional Polypeptoids by Post-polymerization Modification
Methods
Still considered relatively young in the field of peptidomimetic materials, side
chain modification to introduce specific functionalities is important for controlling the
properties of polypeptoids for biotechnological, technical, and biomedical applications.
To date, very few examples have been reported describing the modification of Nsubstituents in polypeptoids by “click” chemistry.33 Discovered by Sharpless et al., click
chemistry refers to modular reactions that permit the highly efficient chemical bond
formation between different types of functionalities under mild conditions.34,35 Using click
chemistry, the incorporation of bioactive groups, targeting moieties, and solubility
enhancing groups into polymers have been accomplished.36,37 In terms of modification,
polymers containing side chains with functional groups such as allyl41 or propargyl33,39
enable “click” chemistry methods to be used for further structural alteration.
Characteristically, click reactions are denoted by features including high bondformation efficiency, high yields, easy purification from byproducts, and high
stereoselectivity.34,35 Prime examples of “click” chemistry, thiol-ene reaction and copper
catalyzed azide-alkyne cycloaddition (CuAAC), have been heavily used to introduce
new moieties to polypeptoids and hence will be discussed here.
A wide range of enes and thiols can undergo thio-ene addition chemistry to afford
thioether moieties, making it a versatile method for post-polymerization modification of
polymers.34 Schlaad et al. reported the post-polymerization modification of poly(N-allyl
glycine) via photoinitiated thiol-ene addition chemistry.38 Thiol–ene additions of poly(Nallyl glycine)s with 1-thioglycerol, 1-thio--D-glucose tetraacetate, and 1-thio--Dglucose were demonstrated. It was shown that the glycosylation of poly(N-allyl glycine)s
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was readily achievable under environmentally benign conditions (i.e., in an aqueous
solution at room temperature). Moreover, the thiol-ene reaction could be successfully
carried out in the presence or absence of a photo initiator hydroxy-4’-(2-hydroxyethoxy)2-methylpropiophenone (HEMP), though the addition rate was found to be considerably
higher in the ﬁrst instance.
Zhang et al. previously investigated cyclic brush-like polymers which were
synthesized by tandem organo-mediated zwitterionic polymerization followed by the
CuAAC modification with azido-terminated PEG via a grafting-onto approach.40 In
addition to poly(N-propargyl glycine) homopolymer macrocycles, cyclic poly(N-propargyl
glycine)-ran-poly(N-butyl glycine) random copolymers were also studied. As evidenced
by AFM analysis, grafting densities in the latter case with the copolymer were noticeably
higher (<94%), which was attributed to the reduced aggregation of the polymers in
solution and thus enhanced access of the propargyl groups (Figure 2.3).40 By combining
the primary amine-initiated ring-opening polymerization method with CuAAC click
chemistry Zhang et al. also reported the ﬁrst redox-responsive core-cross-linked
micelles (CCLMs) based on amphiphilic block copolypeptoids.41 Sequence-defined
peptoids prepared by sequential CuAAC conjugation reactions on a solid support have
also been demonstrated by Kirshenbaum et al. (Figure 2.4).43,44 This on-resin click
approach was also applied to glycosylated peptoids for antifreeze applications.45
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Figure 2.3. Synthesis of cyclic polypeptoid brushes (top) and AFM amplitude images of
corresponding donut-shape structures (bottom). (Reprinted (adapted) with permission
from reference40. Copyright © (2011) American Chemical Society.
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Figure 2.4. Synthesis and modification of oligopeptoids via CuAAC chemistry.
(Reproduced from Ref. 43 with permission from The Royal Society of Chemistry).

Schlaad et al. recently described the potential of poly(N-propargyl glycine) (PNPgG) as
a versatile platform for post-polymerization modiﬁcation of polypeptoids (Scheme 2.3).33
Interestingly, the quaternization of triazole linkers with an alkyl halide following CuAAC
resulted in the first example of a polypeptoid ionic liquid. In addition, it was shown that
acetylide anions produced by deprotonation of the alkyne proton by phosphazene base
served as an initiator for the polymerization of ethylene oxide, further highlighting the
versatility of propargyl groups for further chemical derivation. The crosslinking of
PNPgG by thermal treatment at high temperatures (greater than 190 ºC) was also
demonstrated, resulting in an insoluble amorphous network which could be useful for a
stabilization of bulk materials or films as well as block copolymer aggregates.33 More
recently, use of CuAAC click chemistry was employed to introduce charged moieties
onto the homo- and random polypeptoids to access a library of cationic polypeptoids for
gene delivery application as shown by Yin et al.46
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Scheme 2.3. Synthesis of poly(N-propargyl glycine) and subsequent modifications of
alkyne side chains. (Reprinted with permission from reference 33, copyright (2017)
Elsevier).
Synthetic strategies discussed in this chapter have set the stage for the further
investigation of the structure-property relationship of polypeptoids. Due to the versatility
offered by the post-polymerization modification methods, scientists can now prepare
functional polypeptoid materials for different applications.
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CHAPTER 3: CATIONIC POLYPEPTOIDS TOWARDS EFFICIENT NON-VIRAL
GENE DELIVERY
3.1 Introduction
Gene therapy has been widely regarded as a promising modality to treat various
human diseases, including cancer, infectious diseases, and immunodeficiency.1-7 High
transfection efficiency and low toxicity are the two basic requirements for gene delivery
vectors.8-12 Cationic polymers (also referred to as polycations), a major category of nonviral gene vectors, feature potent gene condensation capabilities to promote the cellular
internalization, and thus have received wide applications as gene transfection
materials.13-19 However, the relatively low transfection efficiency still remains a critical
issue for polycations, which is mainly attributed to the various biological barriers that
render the rational design of polycations challenging. Therefore, it is highly demanded
that the structure-property relationship of polycations be systemically unraveled, such
that their molecular characteristics could be optimized to synergistically overcome the
multiple cellular barriers against effective gene transfection.
Because of the sidechain substitution on the nitrogen atom, polypeptoids lack
extensive hydrogen bonding and mainchain stereogenic center that are typical for
polypeptides. It thus allows the physicochemical properties of polypeptoids (e.g.,
conformation, solubility, thermal property, and crystallinity) to be tuned by controlling the
sequence, sidechain chemistry, and molecular architecture.20-24 As such, synthetic
polypeptoids have been widely applied for non-fouling coating,25 antimicrobial
therapy,26-28 drug delivery,29-30 and etc..31 More importantly, polypeptoids are stable
against proteolytic degradation, which allows them to maintain structural integrity under
physiological conditions and thus makes them better-suited for certain biomedical
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applications in vivo.32-33 There is evidence that polypeptoids are more membrane
permeable than structurally analogous peptides.34-35 However, studies on polypeptoids
as gene delivery vectors are limited.36 While oligopeptoids have been previously
explored for gene delivery,37 they were synthesized by the solid-phase submonomer
method which suffered from low yields (less than 20%) and limited chain length.38
3.2 Synthesis of Cationic
polymerization Strategies.

Polypeptoids

by

Polymerization

and

Post-

I have pursued the synthesis of cationic polypeptoids by a combination of
polymerization and post-polymerization modification using either radical thiol-ene or
copper-mediated alkyne-azide cycloaddition (CuAAC) “click” chemistry. This strategy is
chosen due to the possibility to access a large library of structurally diverse cationic
polypeptoids from a common precursor. This will enable the systematic investigation of
structure-function relationship to identify optical molecular motifs for gene transfection
application. Specifically, N-ally N-carboxyanhydride (Al-NCA) has been polymerized to
produce the poly(N-ally glycine) which is further derivatized by radical thio-ene
chemistry to install the cationic moieties on the sidechain. Alternatively, N-propargyl Ncarboxyanhydride (Pg-NCA) monomer was polymerized to yield poly(N-propargyl
glycine) followed by CuAAC chemistry to access cationic polypeptoids. Both “click”
chemistry used in the post-polymerization modification step have successfully led to the
desired cationic polypeptoid products. However, the water solubility of the resulting
cationic polypeptoids from the two methods is vastly different presumably due to the
disparate linker structures (i.e., thioether versus triazole functionality) formed during the
“click” chemistry (Scheme 3.1). This has significant implication on their potential uses as
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non-viral gene delivery carriers. The details of the research findings will be discussed in
the following sections.

Scheme 3.1 Click chemistry that have been investigated to make cationic polypeptoids.
3.3. Synthesis and Characterization of Poly(N-allyl glycine) (PNAlG) Polymers
The synthesis and polymerization of N-Allyl NCA (Al-NCA) was first reported by
Schlaad and coworkers.43 Briefly, poly(N-allyl glycine)s (PNAlG) polymers with Mn in the
1.5–10.5 kg mol-1 range and PDI = 1.1–1.4 were synthesized by primary amine-initiated
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ROP of Al-NCAs. The polymers can be readily dissolved in organic solvents and water.
Post polymerization modiﬁcations of PNAlGs with unprotected thiosugars by thiol-ene
chemistry can be conducted in an aqueous medium. Polymerization of Al-NCA and
post-modification by thiol-ene chemistry represents an attractive route to access
structurally diverse polypeptoids derivatives. Inspired by Schlaad work, I investigated
the synthesis of cationic polypeptoids by a combination of ROP of Al-NCA and postpolymerization modification of the PNAlG polymers by radical thiol-ene chemistry to
install the cationic moieties on the N-substituent.
Polymerization of Al-NCA using benzylamine initiators in different initial
monomer-to-initiator feed ratios ([M]0:[I]0) have been investigated in THF at 50 oC. FTIR spectroscopy has proven to be a reliable and convenient tool in the monitoring the
reaction progress, as the Al-NCA monomer exhibits characteristic carbonyl C=O
stretching bands at 1857 cm-1 and 1757 cm-1 that are distinctly different from the
resulting polymer with carbonyl C=O stretching band at ~1654-1659 cm-1. It typically
takes 18-24 h for the ROP of Al-NCA to reach quantitative conversion. The resulting
polymers were isolated and purified by the addition of excess hexane followed by
decantation and drying via high vacuum to afford a white powder. The polymer
composition, molecular weight and molecular weight distribution of the resulting
polymers have been characterized by

1

H NMR spectroscopy and size-exclusion

chromatography (SEC) methods (Table 3.1). The polymer chain lengths for PNAlG
polymers were determined by the integration of alkene protons of allyl side chains at
5.81 ppm relative to the aromatic protons of the benzyl end group at 7.26 ppm in their
respective 1H NMR spectra (Figure 3.1). There was an excellent agreement between
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the experimental molecular weight (Mn) determined by 1H NMR and SEC with the
theoretical prediction in the low molecular weight range ([M]0:[I]0 < 50:1, Mn<5kg/mol)),
indicating good control of polymerization. In agreement with earlier reports by Schlaad
and Luxenhofer, deviations in Mn were observed with increasing chain lengths of PNAlG
above 50 mer (Figure 3.2).43-44 SEC analysis also revealed fairly broad and multimodal
molecular weight distributions for PNAlG samples with PDIs= 1.2-1.4. The presence of
high molecular weight shoulders (Table 3.1 and Figure 3.2) is attributed to the
aggregation of PNAlG polymers in the DMF/LiBr (0.1M) solvent used in SEC analysis.
Schlaad et al. has previously reported that PNAlG along with other poly(C-3 Nsubstituted glycine) polymers can undergo intra-chain hydrogen-bonding, reducing
solvation by surrounding solvent by shielding the polymer backbone.44
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Figure 3.1. Representative 1H NMR spectrum of PNAlG polymers in CD3CN.

Table 3.1 Molecular characteristics of PNAlG polymers obtained by benzylamine–
initiated ROP of Al-NCA in THF at 50 ºC.
[M]0:[I]0

[M]0

Mn (theor.)
(kg/mol-1)

Mn
(NMR)a Mn (SEC)b
(kg/mol-1)
(kg/mol-1)

SEC (PDI)b

25:1

.5M

2.5

2.1

2.8

1.4

50:1

.5M

4.9

3.7

4.5

1.3

75:1

.5M

7.4

6.6

6.1

1.3

100:1

.5M

9.8

7.4

7.7

1.2

a.

Polymer composition determined by integration of alkene protons relative to benzyl end group.
Experimental molecular weight and polydispersity index are obtained from a tandem SECMALS-DRI system in 0.1 M LiBr/DMF solution dn/dc of 0.0950 mL•g-1.
b.
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Figure 3.2 Normalized SEC chromatogram (0.1 M LiBr/DMF, 25 ○C) of PNAlG polymers.
Experimental Mns (2.8-7.7 kg/mol) and PDIs (1.2.-1.4) of the polymers that were
synthesized via benzylamine-initiated ring-opening polymerization of Al-NCA (Table
3.1).
3.4. Grafting of Neutral Thiol Compounds
Free thiols were reacted with PNAlG homopolymers via the photo-initiated radical
thiol-ene addition reaction (Scheme 3.2). 1-Chloro-3-propane mercaptan (CPT) was
initially investigated in this reaction for the consideration of further derivation by Sn2
substitution chemistry to install various cationic moieties, thus producing a library
cationic polypeptoids.
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Scheme 3.2. Proposed synthesis of cationic polypeptoids via modification of PNAlG by
radical thio-ene addition chemistry with 1-chloro-3-propane thiol (CPT) and nucleophilic
substitution (using tertiary heteroatom compounds).

PNAlG polymers were pretreated with methanol and dried prior to thiol
conjugation to prevent aggregation.43 PNAlGs were subjected to UV irradiation In the
presence of a photo-initiator and CPT. In all cases quantitative grafting of thiols to the
PNAlGs was observed as evident by the disappearance of allylic protons at 5.86 ppm
and 5.32 ppm in 1H NMR analysis (Figure A.1). The chain lengths of the resulting
polymers were determined by the integration of -CH2 protons of polymer backbone
relative to the aromatic protons of the benzyl end group in the 1H NMR spectrum (Figure
A.1). Prior to the thiol-ene reaction, the PNAlG polymer is a white powder. Post thiolene reaction, the resulting polymers appear yellow and sticky in texture. While PNAlG
polymer precursor was fully water soluble, the resulting polymers post thiol-ene addition
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become water insoluble, presumably due to the enhanced hydrophobicity of the
additional thiol-alkyl ether linkages on the sidechain.
3.5. Grafting of Cationic Thiol Compounds
To improve the water solubility of the polypeptoids bearing the thio-ether
sidechain, I investigate the grafting of a positively charged thiol compound by radical
thio-lene chemistry. I postulated that presence of cationic groups along polymer side
chains would counteract the enhanced hydrophobic character due to the thiol-alkyl ether
sidechain, thus resulting in enhanced solubility of the polymers in water. Various
cationic alkyl mercaptan compounds were submitted to radical thiol-ene click addition
with PNAlGs as depicted in Scheme 3.3. However, this approach led to no reaction with
recovery of PNAlG starting material. Because no issues were encountered with the
grafting of thiol groups neutral in charge, I presume that charge repulsion between the
cationic thiol derivatives following thiyl radical formation occurred. The consequence of
this is the suppressed interaction of thiyl radicals with polymer alkene groups for
grafting.

Scheme 3.3 Attempted synthesis of cationic polypeptoids via radical thiol-ene addition
reaction using positively charged thiol compounds.

43

3.6. Synthesis of Thiol Compound with Enhanced Water Solubility
I also investigated the conjugation of PNAlG polymers with 2-mercaptoethanol
via radical thiol ene chemistry. The grafting efficiency was quantitative as evidenced by
the disappearance of -CH=CH2 proton signals in the allylic region (5.72 ppm and 5.01
ppm) of 1H NMR (Figure 3.3). The backbone degree of polymerization of the resulting
polypeptoids can be determined by integration of -CH2 protons of polymer backbone
relative to the aromatic protons of the benzyl end group in the 1H NMR spectrum. It is
encouraging to find that the resulting polymers are water soluble. It is clear from this
result that to enhance the water solubility of polypeptoids bearing thiol-alkyl ether
linkages, the relative hydrophilicity and lipophilicity content of the thiol compounds has
to be increased.

Figure 3.3 Representative 1H NMR spectrum of 2-mercaptoethanol-modified PNAlG in
CD3OD.
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One idea is to use thiols bearing some oligomeric ethylene glycol structure motif and a
suitable leaving group (Scheme 3.4) in the thiol-ene reaction with PNAlG. The presence
of oligomeric ethylene glycol linker is expected to increase the water solubility of
resulting polypeptoids from thiol-ene addition. The leaving group will allow for further
installation of cationic moieties by substitution reaction post thiol-ene conjugation. The
targeted thiol compound was synthesized in an overall yield of 35.8% by a multi-step
reaction scheme as illustrated in Scheme 3.4. All intermediates (Figures A.2-A.5)
leading up to the final thiol compound (Figures A.6 and A.7) were characterized by NMR
spectroscopy. With the thiol compound in hand, I investigated the radical thiol-ene
method to conjugate this moiety to the PNAlG polymer. After multiple attempts, the
reaction was unsuccessful in producing the desired polypeptoids bearing thiol-ether
sidechains. This is tentatively attributed to the competing radical oligomerization of the
thiol compound of its own via the thiol-halide substitution.45

Scheme 3.4 Synthesis of 2-(2-(2-iodoethoxy)ethoxy)ethanethiol.
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3.7. Synthesis of PNAlG-r-PNMeG Random Copolypeptoids
Having failed at different tactics to develop water-soluble cationic polypeptoid
homopolymers, I set to investigate the synthesis of a copolypeptoids precursor that are
less hydrophobic than PNAlGs by the copolymerization strategy.52,53 Polysarcosine
polymers obtained from ROP of Me-NCA is highly water soluble and has been studied
as biomaterials for various biomedical applications. Hence, I conducted the
copolymerization of Al-NCA and Me-NCA using benzylamine initiator, producing a
random copolypeptoid to be used in the subsequent thiol-ene addition reaction (Figure
A.10).
The random copolypeptoids (PNAlG-r-PNMG) can be readily dissolved in water
prior to radical thiol-ene coupling as expected, but there are constraints. The water
solubility of the resulting polypeptoids was found to be dependent on the composition of
allyl segment present in the PNAlG-r-PNMG precursors. While PNAlG4-r-PNMG39 with
9% N-allyl glycine content was water-soluble, PNAlG20-r-PNMG23 comprised of 47% Nallyl glycine content was insoluble in water. This was a major drawback as carriers for
gene delivery need to be water soluble in order to be used. Because of the precursor’s
inability to dissolve in water, radical thiol-ene addition experiments were carried out
using PNAlG4-r-PNMeG39. Conjugation of PNAlG4-r-PNMeG39 with CPT via radical thiolene reaction was successful. Quantitative grafting of CPT thiol to the copolymers by
radical thiol-ene chemistry was evidenced by the total disappearance of allylic protons
as illustrated in Figure A.10. Subsequently, use of the Sn2 reaction with trimethyl
phosphine was performed to obtain the positively charged moiety from PNAlG4-rPNMG39-CPT (Figure A.11). Upon conjugation with the tertiary phosphine solvation of
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the cationic, thiosulfide containing copolymer by water was retained. Unlike the case
with CPT-functionalized copolypeptoid precursors, the composition and degree of
polymerization of the final cationic random copolypeptoids cannot be accurately
determined from 1H NMR spectrum due to the severe overlap of relevant proton peaks
(Figure A.11).
While the copolymerization method is viable for the synthesis of water-soluble
cationic polypeptoids the low PNAlG content in the copolypeptoids ultimately limit the
usefulness of this approach. For a comprehensive understanding of structure-property
relationship pertinent to nonviral gene delivery, a synthetic platform that allows for facile
and modular tuning of the molecular characteristics is needed.

3.8. Synthesis of Water-Soluble Cationic Polypeptoids by ROP of N-Propargyl Ncarboxyanhydride (Pg-NCA) and Post-Polymerization Modification via Copper
Catalyzed Alkyne-azide Cycloaddition (CuAAC) Method
After

encountering

much

difficulty

in

accessing

water-soluble

cationic

polypeptoids via the post-polymerization modification of PNAlG polymers by radical thioene chemistry, I switched my focus to investigate an alternative strategy towards
cationic polypeptoids. This involves the polymerization of N-propargyl NCA to first afford
poly(N-propargyl glycine) precursors followed by copper-catalyzed alkyne-azide
cycloaddition chemistry to install cationic moieties. This is based on the consideration
that triazole linkers resulted from the CuAAC chemistry is more polar than the thio-ether
linkages obtained by thio-ene chemistry and will lead to cationic polypeptoids with
enhanced water solubility. This strategy proves to be very effective in the synthesis of a
variety of water-soluble cationic polypeptoids. The details of the synthesis and
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characterization of these cationic polypeptoids will be discussed in the following
sections.
3.9. Synthesis and ROP of Pg-NCA Monomer
The synthesis of N-propargyl NCA was previously reported. It involves the
reductive amination of glyoxylic acid with propargyl amine (Scheme 3.5). The reaction
appears to be sensitive to the source and purity of glyoxylic acids. In multiple attempts,
the reaction stops at the imine intermediate without the formation for the desired Npropargyl glycine product. Alternative strategies that involve the substitution of
brominated acetyl derivatives46 with propargyl amine prove to be more reliable in
accessing N-propargyl glycine in high yield. Subsequent hydrolysis and Boc protection

followed by PCl3-mediated cyclization afforded the desired Pg-NCA in good yields.
Scheme 3.5 Synthetic routes for N-propargyl glycine, the precursor to the Pg-NCA
monomer.

Ring-opening polymerization of Pg-NCA was investigated using benzyl amine
initiators in varying initial monomer-to-initiator feed ratio ([M]0:[I]0) to access poly(N-
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propargyl glycine) (PNPgG) polymers. All reactions were conducted at .5M in THF and
50 °C for 18-24 hours to reach quantitative conversions. The number average degree of
polymerization (DPn) for PNPgG polymers were determined using

1

H NMR

spectroscopy by integrating the alkyne proton of propargyl side chains at 2.30 ppm
relative to the aromatic protons of the benzyl end group at 7.23 ppm (Figure 3.5). The
PNPgG polymers were also analyzed by the SEC-MALS-DRI method to determine the
absolute polymer molecular weight and molecular weight distribution. The PNPgG with
Mn in the range of 2.8-23.9 corresponding to DP= 28-250 and PDI in the 1.03-1.18
range can be obtained by adjusting the [M]0:[I]0 ratio (Figure 3.4). The SEC traces
(Figures 3.4 and 3.6) appear multi-modal for sample samples, which have been
attributed to the aggregation of the PNPgG polymers in the SEC solvent (DMF/LiBr
(0.1M).23 It has been found that stirring PNPgG polymers for 18 h at room temperature
in DCM, a better solvent than DMF, prior to the SEC analysis can significantly reduce
the level of aggregation (Figure 3.6). Copolymerization with other NCAs (e.g., N-Decyl
NCA) have also shown to be effective in reducing aggregation (Table 3.2 and Figure
A.12).
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Table 3.2. Cationic polypeptoids with various DPs and sidechain structures.
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Figure 3.4. Normalized SEC chromatograms (0.1 M LiBr/DMF, 25 °C) of the PNPgG
polymer with various backbone lengths (DP = 28, 46, 135, and 250, Mn = 2.8, 4.5, 12.9,
and 23.9 kg/mol, PDI = 1.03−1.18) synthesized via the benzylamine-initiated ROP of
Pg-NCA.
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Figure 3.5. Representative 1H NMR spectrum of the poly(N-propargyl glycine)
homopolymer (PNPgG) in CD2Cl2. (CD2Cl2), δ ppm: 7.23−7.19 ppm (br m, −C6H5, Ha),
4.67−4.04 ppm (br m, −COCH2N−, −CCH2N−, Hb, Hc), 2.66−2.30 ppm (br m,
−CHCCH2−, Hd).
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Figure 3.6 SEC chromatograms of PNPgG before and after DCM treatment.

3.10. Post-polymerization Modification of PNPgG with Cationic Azido Compounds
by CuAAC Chemistry
With PNPgG polymers having different chain length available, I set to synthesize
a series of cationic azido compounds that will be subsequently conjugated to the
PNPgG polymers by CuAAC chemistry. I designed a library of cationic molecules
bearing one azido group and one cationic ammonium moiety that are separated by a
flexible alkyl linker. This structural design allows a variety of cationic moieties to be
introduced in a modular manner, as shown in Scheme 3.6. With the presence of cationic
groups, it is reasoned that the subsequent conjugation to PNPgG polymers by CuAAC
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chemistry should be facilitated as the level of aggregation of the resulting polymers
should be reduced due to electrostatic repulsion of the charged moieties.

Scheme 3.6 Synthesis of various cationic azido compounds.
I have synthesized a library of cationic azido compounds 1-10 by the method
shown in Scheme 3.7 and verified their structures by 1H NMR spectroscopic analysis
(Figures A.14-A.17 *Selective structures 1, 7, 8, 10). The conjugation of the cationic
azido compounds with PNPgG polymers was then investigated. All reactions were
conducted with the propargyl group to azido group in 1: 2 ratio at 50 °C in DMF for 18 h
in the presence of 33 mol% CuBr and 33 mol% PMDETA ligand (Scheme 3.7). At
completion of cycloaddition, to remove copper from the reaction an aqueous solution of
EDTA (9.9 mM, 3 mL), was added directly to a reaction mixture prior to dialysis against
DI water for 24-48 h during which the DI water was changed twice a day. Next, the
reaction mixture was then lyophilized to yield a light green powder in good yields (~6095%). To measure copper content of cationic polypeptoids following dialysis Flame
Atomic Absorption Spectrometry (FAAS) was performed using a series of solutions for a
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calibration curve (1 ppm-10 ppm) that were prepared from copper (II) standard at the
concentration of 1 mg/mL. The resulting cationic polypeptoids were readily soluble in
water. 1H NMR analysis of the cationic polymers (Figures 3.7 and A.21-A.31) in D2O
revealed the disappearance of the propargyl proton at 2.30 ppm and appearance of the
triazole proton at 8.01 ppm, indicative of quantitative conversion by the CuAAC
chemistry. The number average degree of polymerization (DPn) of the resulting cationic
polypeptoids can also be determined by the integration of the triazole proton (d) relative
to the aromatic protons (a) of the benzyl end group in the 1H NMR spectrum. After
CuAAC chemistry, the DP of positively charged polypeptoids often appear reduced as
compared to the DP of their neutral polypeptoid precursors. This may be attributed to
differential solvation of polypeptoids chains or polymer aggregation in deuterated
solvent (D2O) used in the NMR analysis, resulting in incomplete relaxation of various
protons of cationic polypeptoids and rendering errors in the estimation of their DPs. It
should be noted that addition of a small aliquot of trifluoroacetic acid (TFA) to D2O did
not affect the relative proton integration for the cationic polypeptoids, even though this
has previously been shown to be effectively in reducing aggregation of polypeptides in
solution.
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Figure 3.7 Representative 1H NMR spectra of A) PNPgG (before CuAAC), B) cationic
alkyl azide compound 2 (Scheme 3.6), C) cationic polypeptoids obtained after CuAAC
chemistry.
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Scheme 3.7 Synthesis of cationic polypeptoids from various cationic alkyl azides and
PNPgG polymers using CuAAC chemistry.

3.11. Optimizing the Molecular Characteristics of Cationic Polypeptoids Toward
Efficient Non-Viral Gene Delivery
As I have demonstrated that water soluble cationic polypeptoids with tunable
molecular characteristics can be accessed by a combination of ring-opening
polymerization of Pg-NCA and CuAAC chemistry, a collaboration with the Yin group at
Soochow University was initiated to systematically investigate the structure-property
relationship towards gene delivery using cationic polypeptoids. In particular, I
synthesized a series of polypeptoids with different cationic side-chain terminal groups,
degree of polymerization, side-chain lengths, and incorporated aliphatic side chains.
Their DNA condensation capability, DNA release, cellular uptake, intracellular kinetics,
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transfection efficiency, and cytotoxicity were comprehensively evaluated, in attempt to
identify the optimal polypeptoid structure with maximized gene delivery efficiency while
minimized cytotoxicity. Herein, my synthetic contributions will be discussed. Results of
assessments of cationic polypeptoids for gene transfection will also be mentioned.
3.12. Results and Discussion
3.12.1 Design, Synthesis, and Characterization of Cationic Polypeptoids
I

synthesized

a

series

of

cationic

polypeptoids

with

varied

molecular

characteristics (e.g., backbone length, side-chain length, different charged side terminal
groups, and incorporated hydrophobicity) (Scheme 3.8 and Table 3.2). PNPgG with
different Mns were first synthesized via benzylamine-initiated controlled ring-opening
polymerization (ROP) of the corresponding Pg-NCA monomers (Scheme 3.8). The
resulting PNPgG with Mn of 2.8-24 kDa (DPn = 28-251) and PDI of 1.08-1.48 was
obtained, as characterized by SEC-MALS-DRI and NMR analysis (Figure 3.4-3.5, Table
3.2, and Figure A.13). A series of cationic polypeptoids were then synthesized by postpolymerization modification of the PNPgG with various -azido alkyl ammonium salts
(Scheme A.18) using the “click” chemistry (Scheme 3.7). The side-chain derivation was
quantitative in all cases, evidenced by the complete disappearance of the terminal
alkyne proton of propargyl group at 2.51 ppm and appearance of the triazole proton at
8.0 ppm from the 1H NMR analysis (Figures A.21-A.31). The cationic polypeptoids were
purified by treatment with EDTA to remove copper salts followed by extensive dialysis
against DI water. Upon lyophilization, all polymers were obtained as white to pale green
powders in good yield (60-96%) with copper ion content in the sub-10 ppm range based
on the atomic absorption analysis, which was significantly lower than the concentration
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threshold that would otherwise cause potential copper ion-induced cytotoxicity. P1-P4
carried different cationic side-chain terminal groups (primary, secondary, tertiary, and
quaternary amine) at the fixed DP of 46; P4-P7 possessed primary amine as the side
terminal group while had different DPn (28, 46, 134, and 251); P8-P10 had the same DP
(46) and side terminal group (primary amine), while afforded different spacer lengths
between the triazole and amine (3, 4, 5, and 6 methylene groups) (Table 3.3). Chemical
structures of the cationic polypeptoids were verified by 1H NMR spectroscopy. All the
resulting cationic polypeptoids afforded desired aqueous solubility, and thus could be
readily used to complex DNA and mediate gene transfection in the aqueous medium.

Scheme 3.8. Synthetic routes of a library of cationic polypeptoids bearing different
amino groups (P1−P4), DPs (P4−P7), hydrophobic sidechain lengths (P4, P8, P9, and
P10), and aliphatic modiﬁcation of the sidechains (P11).
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P11 bearing a fraction of hydrophobic N-decyl side chains (Figure A.31) was
similarly synthesized and characterized via modification of the P(NPgG-r-NDeG)
random copolymer with -azido hexyl ammonium salt using “click” chemistry (Scheme
3.8). The P(NPgG-r-NDeG) copolymer precursor was synthesized by copolymerization
of Pg-NCA and De-NCA using benzyl amine initiator and characterized by SEC-MALSDRI and NMR analysis (Figures A.12, A.19 and A.20). P11, a random copolypeptoid
analogue of P10, contained both primary amine groups (with 6 methylene groups
between triazole and amine) and hydrophobic decyl groups on side chains, at the DP of
48 that was similar to P10 (Table 3.2).
3.12.2. Formation and Characterization of Polypeptoid/DNA Polyplexes
DNA condensation by the cationic polypeptoids was first evaluated by the gel
retardation assay. All the positively charged polypeptoids were able to condense DNA
at the polypeptoid/DNA weight ratio ≥ 2.5, indicating complete condensation of DNA by
the positively charged polypeptoids. Such results were further confirmed by a
quantitative EB exclusion assay (Figure 3.8), wherein more than 80% of the DNA was
condensed at the polypeptoid/DNA weight ratio ≥ 2.5. Polypeptoids with different
charged groups (P1-P4) or with different side-chain length (P4, P8, P9, and P10)
showed similar DNA condensation profiles.
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Figure 3.8. DNA condensation efficiencies of polypeptoids at various polypeptoid/DNA
weight ratios as evaluated by the EB exclusion assay (n = 3). (A) Polypeptoids with
different cationic side-chain terminal groups. (B) Polypeptoids with different DPs. (C)
Polypeptoids with different hydrophobic side-chain lengths and incorporated
hydrophobic decyl side chains.
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In

comparison,

longer

polypeptoid

backbone

correlated

to

enhanced

DNA

condensation level. DNA condensation levels as shown by the EB exclusion assay was
represented by the order of P7>P6>P4>P5, mainly due to the facilitated entanglement
of longer polypeptoids with DNA molecules (Figure 3.8B). Enhanced DNA condensation
levels of polypeptoids as a result of presenting hydrophobicity were observed. P11 with
introduced aliphatic decyl side chains afforded higher DNA condensation level than its
un-modified analogue P10 despite its lower content of cationic group (Figure 3.8C),
indicating that the hydrophobic interaction with DNA would provide additional forces to
drive the assembly between polymer and DNA. As a result of their DNA condensation
capabilities, all tested polypeptoid/DNA polyplexes, at the weight ratio higher than 2.5
displayed positive surface charges that would facilitate binding to cell membranes
toward effective cellular internalization.
3.12.3. In Vitro Gene Transfection with Polypeptoid/DNA Polyplexes
Several molecular characteristics of polypeptoids were adjusted and tested for
gene delivery to examine the structure-relationship property on transfection efficiency.
Polypeptoids containing fixed DP (46) and side-chain length yet different side charged
groups (P1, P2, P3 and P4) were first evaluated in terms of the transfection efficiency in
HeLa cells in serum-free medium (Figure 3.9A). Remarkably higher transfection
efficiencies were displayed with analogues bearing primary amine than those containing
secondary, tertiary, or quaternary amines. As such, based on the structure of P4 with
primary amine as the optimal cationic charged group, the DP of polymers was varied
(P4, P5, P6 and P7) to explore the effect of backbone length on the gene transfection
capabilities. As shown in Figure 3.9B, an increase of polymer DP from 28 (P5) to 46
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(P4) resulted in significantly enhanced transfection efficiency, presumably attributed to
the enhanced DNA condensation and interactions with cell membranes.
Enhancing hydrophobicity of polymers often facilitates the hydrophobic interaction
with cell membranes to promote cellular internalization. To this end, we prepared
polypeptoid analogues of P4 (DP = 46, 3 methylene groups between triazole and
primary amine) with increased hydrophobic side chain lengths (P8, P9, and P10, with 4,
5, and 6 methylene groups between triazole and primary amine, respectively). As
expected, the transfection efficiencies of polypeptoids in HeLa cells increased when the
hydrophobic side-chain length was prolonged (Figure 3.9C), presumably due to
enhanced membrane activities of the polymers to facilitate intracellular internalization of
DNA cargoes. P10 showed the highest transfection efficiency at the low polymer/DNA
weight ratio of 2.5, outperforming commercial transfection reagent PEI by ~8 fold.
Random copolymers containing both charged side chains and hydrophobic pendant
groups have been reported to show improved membrane activities compared to
charged homopolymers, presumably due to further increased hydrophobic interactions
with cell membranes. We thus went on to explore whether further enhanced gene
delivery efficiency can be achieved for polypeptoids through a similar strategy. P11,
random copolymer analogue of P10, was synthesized which contained ~20 mol% of
pendent decyl groups. As shown in Figure 3.9D, P11 displayed significantly improved
transfection efficiency over P10 by ~6 fold and it outperformed PEI by ~45 fold, which
substantiated the critical role of introduced hydrophobic aliphatic side chains in
promoting intracellular DNA delivery. Both P10 and P11 achieved the highest
transfection efficiency at relatively low polymer/DNA weight ratio of 2.5 (equals to N/P
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ratio of ~3.6 and ~3, respectively), in comparison to majority of polycation-based gene
vectors that often require high N/P ratios to achieve effective gene transfection (e.g. N/P
= 10 for PEI, N/P = 10 for dendrimers, N/P = 10 for helical polypeptides we developed
before). Such desired property could presumably be attributed to the presence of
hydrophobic domains that strengthened the membrane interactions, such that excessive
cationic polymers are not necessarily required to impose sufficient binding affinities with
negatively charged cell membranes.

Figure 3.9. Transfection efficiencies of polyplexes at various polypeptoid/DNA weight
ratios in HeLa (A−D), B16F10 (E), and COS-7 (F) cells in the absence of serum (n = 3).
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Markedly compromised transfection efficiency in serum serves as a critical
challenge against polycation-mediated non-viral gene delivery. Therefore, the DNA
transfection efficiencies of the top-performing P10 and P11 in the presence of 10% FBS
were monitored in different cell lines. According to Figure A.32, P10 and P11 suffered
from compromised gene transfection efficiencies at the same polypeptoid/DNA weight
ratio of 2.5 when compared to those under serum-free conditions. However, the
transfection efficiencies could be largely recovered at the higher polypeptoid/DNA
weight ratio of 10, probably because the additional cationic charges as well as
hydrophobicity mediated stronger interactions between DNA and polypeptoids that
competitively compensated the DNA replacement by serum. P11 was still able to
maintain high gene transfection efficiencies in the presence of enhanced FBS
concentration that were only several fold lower than those under serum-free conditions
(Figure A.32C), which indicated their potential utilities toward serum-resistant gene
delivery as well as in vivo gene delivery.
3.12.4 Cytotoxicity of Polypeptoid/DNA Polyplexes
Cytotoxicity of polypeptoids and polypeptoid/DNA polyplexes was measured by the
MTT assay. As shown in Figure 3.10，the cytotoxicity of polypeptoids increased when
the polymer concentration or polymer/DNA weight ratio was increased, and
polypeptoids with higher membrane activities correlated to higher cytotoxicity. In all,
bearing primary amine groups, increasing DP, and enhancing the side-chain
hydrophobicity improved cell transfection, but at the expense of elevated cytotoxicities.
Particularly, P11 with pendent decyl groups displayed higher cytotoxicity than its
homopolymer analogue P10 at high concentrations, which further substantiated that the
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excessively high membrane activities would cause irreversible damage to cell viability.
Based on the above transfection and cytotoxicity results, it could be deduced that a
proper balance between membrane affinities and cytotoxicity is demanded to achieve
maximal transfection efficiency, and the excessive membrane activities would decrease
rather than increase the transfection efficiency by notably compromising the cell viability
and transcription/translation functions.
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Figure 3.10. Cytotoxicity of polyplexes at various polypeptoid/DNA weight ratios (DNA
amount was maintained constant at 0.3 μg/well) in HeLa cells as determined by the
MTT assay (n = 3). (A) Polypeptoids with different cationic side-chain terminal groups.
(B) Polypeptoids with different DPs. (C) Polypeptoids with different hydrophobic sidechain lengths and incorporated hydrophobic decyl side chains.
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3.12.5 In Vivo Gene Transfection of Polypeptoid/DNA Polyplexes
The high transfection efficiencies of polypeptoids in vitro in serum-containing
media prompted us to explore the capabilities of these materials toward in vivo gene
delivery. Thus, we further evaluated the in vivo transfection efficiencies of the two topperforming polypeptoids in melanoma-bearing C57/BL6 mice following intratumoral
injection. As shown in Figure 3.11, P11 displayed significantly higher transfection
efficiency than P10, and PEI by ~20 fold, according well with their in vitro transfection
capabilities. These results thus suggested the potential utilities of polypeptoids for the
topical DNA delivery toward anti-cancer gene therapy.

Figure 3.11. In vivo transfection efficiencies of polyplexes following intratumoral injection
in B16F10 xenograft tumor-bearing mice at 40 μg DNA/mouse (n = 4).
3.13. Conclusion
In summary, a library of cationic polypeptoids with different molecular
characteristics were synthesized via the controlled ROP of Pg-NCA and postmodification using Click chemistry, and the structure-property relationship in terms of
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non-viral gene delivery was unraveled. Polypeptoid bearing primary amine side terminal
groups outperformed its analogues containing secondary, tertiary, or quaternary amines
in terms of DNA internalization level and transfection efficiency. Elongating the
polypeptoid backbone potentiated DNA condensation and intracellular uptake, while at
the meantime induced higher cytotoxicity. As such, polypeptoid with DP of 46 displayed
the highest transfection efficiency by achieving an appropriate balance between cellular
internalization and cytotoxicity. Enhancing the hydrophobicity of polypeptoids by either
elongating the aliphatic spacer between backbone and terminal charged groups or
incorporating decyl side chains notably improved the membrane activities and gene
transfection efficiencies. Based on these structural optimization, P11 as the topperforming material was identified which demonstrated potent gene transfection
efficiencies in multiple mammalian cell lines under both serum-free and serumcontaining conditions, outperforming commercial reagent PEI by several orders of
magnitude. These understandings on the structure-property relationship of polypeptoids
provide insight into the design of polymeric gene vectors, and the top-performing P11
may serve as a promising addition to existing gene transfection reagent.
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CHAPTER 4: CATIONIC POLYPEPTOIDS TOWARD TNF-α siRNA DELIVERY
4.1. Introduction
RNA interference (RNAi) has recently emerged as an exciting strategy for the
treatment of various genetic disorder-related diseases.1-8 Small interfering RNA
(siRNA), usually 20-25 base pairs in length, is oligonucleotides that can regulate gene
expression via site-specific mRNA cleavage and degradation.9-12 However, naked
siRNA hardly enter cells due to its negative charges, high molecular weight, and
hydrophilic nature.13,14 Furthermore, the rapid degradation by nucleases seriously limits
it in vivo application.15,16 Hence, a carrier is required to protect siRNA from degradation
and facilitate it effective delivery to the cytosol, which could maximize the in vivo RNAi
efficiency.
Cell

penetrating

peptides

(CPPs),

sequence-specific

oligopeptides,

with

exceptional membrane penetrating properties have been extensively applied to deliver
various cargos, such as proteins, peptides, nucleic acids, metals, and even
nanoparticles.17-19 However, CPPs only poorly condense siRNA due to their short chain
length and lack of sufficient cationic charge density. Additionally, the overall positive
charge of CPPs could be neutralized due to condense the negatively charged siRNA,
thus reducing interaction with negatively charged cell membranes, resulting in
decreased membrane activities and transfection ability.20,21 As a result, CPPs are often
unable to independently mediate effective siRNA delivery.
Polypeptoids, structural analogue of polypeptides, feature facile preparation and
enhanced proteolytic stability, which making them attractive for gene delivery.22-26 To
address the drawbacks of CPPs, we recently developed a library of cationic
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polypeptoids with different structural characteristics and screened them for DNA
delivery.27 The study has enabled the identification of optimal desired structural motifs
that afford high transfection efficiencies for DNA delivery both in vitro and in vivo. Few
studies involving the structure-property relationship in siRNA delivery are available,
which would maximize the siRNA delivery efficiency by optimizing their molecular
characteristics.28-33
Guanidine groups are often abundantly present in the CPPs and play important
roles in mediating effective gene delivery by interacting with the sulfate groups of
glycosaminoglycans in cell membranes.34,35 Additionally, the membrane activity of
guanidine groups can be enhanced by hydrophobic moieties.35,36 Meanwhile, It has
reported that other synthetic polymers where incorporation of optimal hydrophobicity
often leads to enhanced membrane activities.36,37
4.2. Design, Synthesis and Characterization of Cationic Polypeptoids with
Optimized Molecular Characteristics toward TNF-α siRNA Delivery
In chapter 3, we have systematically investigated the structure-property
relationship of cationic polypeptoids towards DNA transfection and identified the
molecular features that led to the most optimal gene transfection efficiency for DNA. It
was found that the cationic polypeptoids bearing primary ammonium terminus and 6
carbon linker and a small fraction (~20 mol%) of hydrophobic decyl sidechains
(introduced via copolymerization) exhibited the most optimal gene transfection
efficiency. Based on these early findings, my synthetic focus was shifted towards
developing structurally similar homopolypeptoids and random copolypeptoids bearing
ammonium or guanidinium cationic moieties towards nonviral gene delivery of TNF-
siRNA to combat systemic inflammation.
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I designed and synthesized a series of cationic polypeptoids with different sidechain terminal groups (primary ammonium and guanidinium), degrees of polymerization
(DP), and incorporation of aliphatic side chains (Scheme 4.2 and Table 4.1). Random
copolypeptoid precursors containing hydrophobic sidechains i.e., PNPgG-r-PNDeG,
were synthesized by copolymerization of Pg-NCA and De-NCA using benzylamine
initiators as previously discussed in Chapter 3 (Section 3.12.1). Cationic azido
compounds containing one azido group and one guanidinium or primary ammonium end
that are separated by 6 carbon linkers were synthesized using the method shown in
Scheme 4.1. The cationic random copolypeptoids bearing ammonium or guanidinium
moieties on the sidechains were similarly obtained using the corresponding cationic
azido compound and the PNPgG-r-PNDeG copolymers by CuAAC chemistry (Scheme
4.2). For the purpose of comparison, cationic homopolymers bearing identical primary
ammonium and guanidinium sidechains were also synthesized by a combination of
polymerization of Pg-NCA and CuAAC chemistry.
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Scheme 4.1. A general synthetic scheme of -azido-alkyl ammonium and guanidinium
compounds.
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Scheme 4.2. Synthetic routes of a library of cationic polypeptoids bearing different sidechain terminal groups (P54, G54), degrees of polymerization (DP) (G30-G103), and
aliphatic modification of the side chains (GD48).

Benzylamine-initiated ROP of Pg-NCA were conducted using different initial
monomer to initiator ratio ([M]0:[I] 0=25:1, 50:1 and 100:1), yielding the corresponding
PNPgG homopolymer with Mn in the 2.9-9.9 kg mol-1 range (DP = 30-103) and PDI in
the 1.01-1.09 range, as determined by the SEC-MALS-DRI analysis (Figure 4.2).
Polymer composition of PNPgG homopolymers were also determined by end-group
analysis using well resolved peaks in 1H NMR spectra (Figure 4.1). For example, the
number average degree of polymerization (DPn) for the resulting PNPgG precursor was
determined by the integration of the propargyl proton (d) relative to the aromatic protons
(a) of the benzyl end group in the 1H NMR spectrum.
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A)

B)

C)

Figure 4.1 Representative 1H NMR spectra of (A) PNPgG homopolymer, (B) -azidoalkyl guanidinium compound, and (C) cationic polypeptoids obtained by CuAAC
reaction. *Residual dioxane

79

Table 4.1. Cationic polypeptoids with various DP and side-chain structures.
Entry

DP (SEC) a

DP (NMR) f

Re

PDI a

Yield
(%)

P54

54

24

-NH3

1.08

91

G30

30

24

Guanidinium

1.09

68

G54

54

37

Guanidinium

1.03

67

G103

103

73

Guanidinium

1.01

79

GD48

48 (m =39 n =9 )b

27 (m =21 n =6)

Guanidinium

a.

1.03 c
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DP and PDI of the PNPgG homopolymer were obtained from the SEC-MALS-DRI
analysis.
b.
DP of the PNPgG copolymer was determined by 1H NMR spectroscopy.
c.
Experimental PDI of polypeptoid copolymer P(NPgG-r-NDeG) was obtained from the
SEC-MALS-DRI analysis using PS standards.
d.
DP of the PNPgG copolymer was determined by 1H NMR spectroscopy.
e.
Types of side-chain terminal groups.
f.
DP of cationic polypeptoids as determined by 1H NMR spectroscopy.
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Figure 4.2. Normalized SEC chromatograms (0.1 M LiBr/DMF, 25 oC) of the PNPgG
homopolymer with varying chain lengths (DPn= 30, 54, and 103, Mn = 2.96, 6.33, and
9.90 kg/mol, PDI = 1.01-1.09) synthesized by benzylamine-initiated ROPs of Pg-NCA.
The Mns were determined using measured dn/dc of PNPgG (0.1012 ± 0.0007 mL/g).
The high molecular weight (MW) shoulders observed are attributed to PNPgG
aggregation in the SEC solvent.

Further derivation of PNPgG homopolymers with different cationic azido
compounds was quantitative in all cases, evidenced by the complete disappearance of
the terminal alkyne proton of propargyl group at 2.51 ppm and appearance of the
triazole proton at 8.0 ppm from the 1H NMR analysis (Figure B.1-B.4). The cationic
polypeptoids were purified by treatment with EDTA to remove copper salts followed by
extensive dialysis against DI water. Upon lyophilization, all polymers were obtained as
white to pale green powders in good yield (67-91%) with copper ion content in the sub10 ppm range based on the atomic absorption analysis. The range of copper content is
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significantly lower than the concentration threshold for potential copper ion-induced
cytotoxicity.38
P54 and G54 (Table 4.1) carried different cationic side-chain terminal groups
(primary ammonium and guanidinium group) at a constant DP of 54; G30-G103
possessed guanidinium side-chain terminal group while had different DP (30, 54, and
103) (Table 4.1). Chemical structures of these cationic polypeptoid homopolymers were
verified by 1H NMR spectroscopy. Compositions for the cationic homopolymers were
determined using 1H NMR spectroscopy by integrating the triazole proton relative at
8.01 ppm relative to the aromatic protons of the benzylamine end group at 7.26 ppm. All
the resulting cationic polypeptoids exhibited good water solubility and can be used to
complex siRNA for gene silencing experiments in the aqueous media.
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Figure 4.3. Representative 1H NMR spectrum of GD48 in D2O.

A cationic random copolypeptoid (GD48, Table 4.1) bearing a small fraction of
hydrophobic N-decyl glycine segments (Figure 4.3) was similarly synthesized and
characterized via modification of the P(NPgG-r-NDeG) random copolymer with -azido
hexyl ammonium salt using CuAAC chemistry (Scheme 4.2). The P(NPgG-r-NDeG)
copolymer precursor was synthesized by copolymerization of Pg-NCA and De-NCA in
[M]0:[I]0= 40:10 ratio using benzylamine initiator. The P(NPgG-r-NDeG) composition was
determined using 1H NMR spectroscopy by integrating the terminal methyl protons of
the decyl group at 0.79 ppm and the alkyne proton of propargyl group at 2.53 ppm
relative to the aromatic protons of benzyl end-group at 7.26 ppm. The molecular weight
distribution of P(NPgG-r-NDeG) copolymer was determined by the SEC-DRI analysis
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using polystyrene standard. Following CuAAC chemistry, the cationic copolymer
composition was determined by integrating the newly formed triazole proton at 8.01
ppm and methylene protons of the decyl group at 0.79 ppm relative to the aromatic
protons of the benzyl end group at 7.32 ppm in the polymers in the 1H NMR spectrum
(Figure 4.4). GD48, with ~80% guanidinium side-chain terminal groups and ~20 mol%
hydrophobic N-decyl sidechains for a backbone DP of 48, was comparable to that of the
cationic homopolymer G54 (DP = 54, Table 4.1).

C)

B)

A)

Figure 4.4 Representative 1H NMR spectra of (A) PNPgG-r-PNDeG random copolymer,
(B) -azido-alkyl guanidinium compound, and (C) cationic polypeptoids copolymer
obtained by CuAAC reaction. *Residual Dioxane

4.3. Formation and Characterization of Polyplexes
A combination of gel retardation assay and EB exclusion assay indicate high
efficiency of siRNA condensation (>80%) with the synthesized cationic polypeptoids at
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polypeptoid/siRNA weight ratio ≥ 10. Polypeptoids with different cationic side-chain
terminal groups (i.e., ammonium or guanidinium) (P54 and G54) showed similar siRNA
binding affinities. In comparison, longer polypeptoid backbone correlated to enhanced
siRNA condensation level mainly due to the facilitated entanglement of longer
polypeptoids with siRNA molecules, wherein the siRNA condensation level was
represented by the order of G103>G54>G30, evidenced by the difference of their EB
exclusion efficiencies. In addition, GD48 bearing a small fraction of N-decyl side chains
afforded higher siRNA condensation level than analogous G54 without the aliphatic
sidechains. This is presumably because the hydrophobic interaction mediated stronger
assembly between siRNA and polymer.
4.4. In Vitro Gene Silencing with Polypeptoid/siRNA Polyplexes
TNF-α

knockdown

efficiencies

of

polypeptoids

with

different

molecular

characteristics were first evaluated in RAW 264.7 cells. The gene-silencing efficiencies
of polypeptoids containing a constant DP (54) but different cationic terminal group on
the sidechain (P54 and G54) were first evaluated. As shown in Figure B.5, G54
containing guanidinium terminal groups displayed remarkably higher gene silencing
efficiency than its analogues containing primary ammonium terminal groups, suggesting
that guanidinium groups played important roles in mediating effective gene delivery
presumably due to their membrane activities. Then, based on the structure of G54
bearing guanidinium charged group, the DP of the polymers was further varied (G30,
G54 and G103) to allow for investigation of the effect of backbone length on the
silencing efficiencies. As shown in Figure B.6, G54 with an intermediate DP displayed
higher silencing efficiency than G30 having a smaller DP, presumably attributed to the
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enhanced siRNA condensation and cellular uptake. However, G103 having the highest
DP exhibited decreased silencing efficiency relative to that of G54. This is presumably
due to the excessively long polymer backbone leading to restricted intracellular siRNA
release and enhanced cytotoxicity. Additionally, the membrane activity of guanidinium
groups can be improved by hydrophobic moieties. We thus went on to explore whether
gene silencing efficiencies can be further enhanced by introducing a smaller fraction of
hydrophobic sidechains to cationic polypeptoids. GD48, containing ~20 mol% of
pendent N-decyl glycine segments and having comparable DP as G54 has been
synthesized and investigated for siRNA delivery. As shown in Figure B.7, GD48
displayed the highest silencing efficiency, significantly outperforming G54 and LPF2000,
in agreement with the literature reported that the hydrophobic moieties can promote
intracellular siRNA delivery.
4.5. In Vivo Gene Silencing
In a mouse model of LPS/D-GalN-induced acute liver failure, D-GalN blocks
gene transcription in the liver, and LPS in turn induces an acute, cytokine-dependent
hepatic inflammation accompanied by massive liver apoptosis and death.40 Therefore,
the extent of TNF-α silencing in vivo using GD48/TNF-α siRNA polyplexes was
investigated. As shown in Figure B.8, i.v. injection of polyplexes significantly depleted
TNF-α mRNA levels in macrophage-enriched organs (liver, spleen, and lung), which
suggested that the polyplexes had infiltrated and efficiently transfected macrophages in
reticuloendothelial tissues to induce significant systemic TNF-α knockdown. Depletion of
TNF-α mRNA levels were further reduced as a result of i.v. injection of polyplexes/ TNFα siRNA at higher dosages, with notably blocked LPS/D-GalN-triggered serum TNF-α

86

production by 74 and 62% respectively (Figure B.8). By contrast, GD48/Scr siRNA
polyplexes did not evoked any RNAi effect.
4.6. Conclusion
In summary, a sequence of cationic polypeptoids with different molecular
characteristics have been synthesized via the controlled ROP of Pg-NCA (and De-NCA)
and post-modification using the CuAAC “click” chemistry. The structure-property
relationship of these cationic polypeptoids in terms of gene silencing was investigated.
GD48, a cationic polypeptoids copolymer with the guanidinium terminal group on the
sidechain, DP of 48 and incorporated aliphatic side chains displayed the highest genesilencing efficiency, outperforming commercial reagent LPF2000. More importantly, the
polypeptoid-based hybrid nanocarrier GD48 mediated effective TNF-α siRNA delivery in
vivo. Consequently, GD48/TNF-α siRNA polyplexes afforded effective systemic
silencing TNF-α and thus demonstrated a potent anti-inflammatory effect to rescue
animals from LPS/D-GalN-induced hepatic sepsis. The potent efficacy in systemically
downregulation of TNF-α, excellent biocompatibility, and simplicity and reproducibility in
formulation of polyplexes would represent an exciting prospect for anti-inflammation
therapies.
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CHAPTER 5: CATIONIC POLYPEPTOID DIBLOCK COPOLYMERS AS POTENTIAL
CARRIERS FOR NONVIRAL GENE DELIVERY IN SERUM
5.1 Introduction
The escalated increase in rare diseases and genetic disorders make gene
therapy practices highly relevant in the field of medicine. Ultimately, for gene therapy
practices to be successful in treating and preventing of diseases and disorders, efficient
gene delivery intracellularly to targeted site and expression is essential. Cationic
polymers continue to thrive as vectors for nonviral gene delivery. As synthetic
compounds, many structural modifications (e.g. MW and ligand attachment) can be
easily achieved as an advantage.1 However, the gene expression efficacy associated
with polymeric vectors face various biological barriers such as those in the extracellular
body fluid, extracellular matrix (ECM), and at the cellular level (cell entry, escape from
endo-lysomal

vesicles,

cytoplasmic

trafficking,

DNA

unpacking,

and

nuclear

translocation of therapeutic DNA). Research efforts sought to overcome this limitation
have included the development of polymers incorporating PEGylation2-4 and
combinatorial chemistry5. In many instances, stimuli-responsive polymers for nonviral
gene delivery have been demonstrated.
Recently, a new class of polysulfoniums capable of gene delivery via degradation
into neutral thioether fragments by triggered reactive oxygen species (ROS) was
reported by Zhu and coworkers.6 It was discovered that a sequence of polysulfoniums
(Scheme 5.1) could efficiently complex DNA into nanosized polyplexes in an aqueous
medium (80 nm). Taking advantage of the elevated ROS levels in cancer cells, the
efficient delivery and release of DNA for gene expression was also achieved. In another
report Stayton et al. described how careful tuning of pH profiles for poly(alkyl acrylic
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acid) polymers could result in higher transfection efficiencies in vitro.7 The key to optimal
cellular uptake and release was found to rely greatly upon the specific choice of
monomer and monomer ratios used during polymerization.

Scheme 5.1. Synthesis and structures of ROS responsive polysulfoniums. (Adapted
with permission from reference6, copyright (2017) John Wiley and Sons).

Interestingly, Yang and coworkers developed polymer systems with a dual response
mechanism for the efficient intracellular delivery of DNA in vitro and in vivo.8 Octaarginine peptides (R8)-conjugated cationic polyamino acid derivatives denoted PPCRC50 and PPCRC-100, synthesized via free radical polymerization and subsequent
aminolysis (Scheme 5.2) were assessed and compared to their peptide lacking

93

analogue (PPCC). From in vitro experiments it was concluded that conjugation of the
synthetic polymers with peptides significantly enhanced the transmembrane and
nucleus import of DNA. At low N/P ratios the PPCRC polyplexes demonstrated the best
transfection efficiency in vitro and in vivo in comparison to PPCC, presumably due to
the ability of the peptides to act as a buffer during endosomal escape. Furthermore,
after incubation of the PPCRC polyplexes with a high concentration of DTT (10 mM), it
was concluded that the cleavage of the disulfide-linkage would promote the rapid DNA
release under conditions mimicking intracellular reducing environments.

PVIm-(PAsp-Cystamine-R8)Cholesteryl (PPCRC)

Scheme 5.2. Synthesis of PVIm-(PAsp-Cystamine-R8)-Cholesteryl
(Reprinted with permission from reference8, copyright (2017) Elsevier).
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(PPCRC).

It is known that transfection efficiencies of cationic polymer systems encounter
issues with colloidal stability in serum-containing media.9 The manifestation of charge
shielding, in which interaction with anionic serum components (lipids, albumin, salts,
etc.) reduces polyplex surface charge, is mainly responsible for this outcome. As a
result of polyplex instability, genetic material becomes displaced throughout cellular
transport resulting in a reduced amount delivered to targeted sites hence, poor gene
expression.
Cationic homo and random polypeptoids with transfection efficacies surpassing
that of high molecular weight polyethylenimine (PEI, a standard gene transfection
carrier) in serum-free media has been previously demonstrated (Chapter 3 and 4).9 To
gain a full understanding of their potential contributions to the field of gene therapy we
must investigate their transfection behavior under conditions relevant to in vivo
environment. Based on their structural composition it was postulated that the pHresponsive block copolymers would condense nucleic acids forming an inner charged
core with by a charge neutral hydrophilic shell, thus minimizing interactions with
extracellular components during transport (Scheme 5.3). The copolymer’s core-shell
architecture was expected to enhance the overall stability of polyplexes during gene
delivery. The hydrophilic shell layer will also contribute to reduced cytotoxicity. Lastly,
presence of the acid-labile linker at the core-shell interface will enable the complete
dissociation of gene/polymer particle at the extracellular compartment under mildly
acidic environment (pH= 5.0) such that the positively charged core can be exposed for
cell internalization.10 It is desirable for dissociation of the core-shell complex to occur
after cell entrance via endocytosis so that the charged core can perform endosomal
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escape. The alkene functional group present at the end of the hydrophilic segment of
the polymer (Scheme 5.4) provides a site for fluorescent labeling and ligand tagging of
the gene/polymer micellar complex, thus imparting the capability for site targeting and
tracking during the gene delivery process.

Scheme 5.3. Dissociation of pH-responsive copolypeptoids for gene delivery in serum.

A key aspect in the development of responsive diblock copolypeptoids relied
upon the synthesis of an initiator that offered dual functionalities (Scheme 5.6). As
depicted in Scheme 5.3, presence of the acetal group within the diamine initiator
provided a feature that is expected to undergo rapid cleavage in low pH environment
following cellular internalization. As a diamine, the initiator would also enable sequential
control over the ring-opening polymerization of NCAs to yield diblock copolypeptoids
that would exhibit a core-shell like morphology upon condensation with genetic
materials.
For comparison purposes, cationic diblock copolypeptoids which lack a pHresponsive linker between blocks were also synthesized and investigated for their gene
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delivery capabilities (Scheme 5.5). As a result of the resemblance of the polymer’s
chemical makeup, the non-pH responsive copolymers served as a control to assess the
effect of pH induced disassembly of micellar carriers on the gene transfection efficiency.

Scheme 5.4. Synthesis and modification of pH responsive block copolypeptoid (AEEPNMeOEt-b-PNPgGs).
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Scheme 5.5. Synthesis and modification of non-pH responsive block copolypeptoid
(PNMeOEt-b-PNPgGs).

5.2. Materials and Methods
5.2.1 General Considerations
All chemicals were purchased from Sigma-Aldrich and used as received unless
specified. All solvents are regular ACS grade solvents and used directly in the reactions
without any special drying or purification step unless specified. 1H and

13

C{H} NMR

spectra were recorded on a Bruker AV-400 or AV-500 spectrometer. Chemical shifts in
ppm were referenced relative to proton impurities or

13

C isotope of deuterated solvents

(e.g., CDCl3, CD3CN, THF-d8). SEC-DRI analyses were performed with an Agilent 1200
system equipped with three Phenomenex 5 μm, 300 × 7.8 mm columns [100 Å, 1000 Å
and Linear (2)], Wyatt DAWN EOS MALS detector (GaAs 30 mW laser at λ=690 nm)
and Wyatt Optilab rEX DRI detector with a 690 nm light source. DMF containing 0.1 M
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LiBr was used as the eluent at a flow rate of 0.5 mLm· in-1. The temperature of the
column and detector was 25 °C.
5.2.2 Synthesis of Mono-protected pH Responsive Initiator (AEE)
Derivation

of

starting

precursor,

2-[1-(2-Amino-ethoxy)-1-methyl-ethoxy]-

ethylamine (AEE), towards the synthesis of the mono-protected responsive initiator was
achieved using a modified procedure initially described by Shim and Kwon.11 N-(2hydroxyethyl)-phthalimide (25 g, 1 equiv) was added to benzene (400 mL), and the
solution was cooled to 0 °C in an ice bath. Next, 2-Methoxy propene (12.5 mL, 1 equiv)
was slowly added into the solution followed by the addition of p-toluenesulfonic acid
(234.1 mg, 0.01 equiv). After stirring for 1 h at 0 °C, the reaction mixture was heated to
evaporate the solvent. Once cooled to room temperature, triethylamine (TEA, 30 mL)
and acetic anhydride (7.5 mL) were added to the mixture and allowed to stir overnight.
The crude product was precipitated from the solution using excess hexanes and further
puriﬁed by recrystallization with ethyl acetate for twice to obtain ﬁnal product compound
4 as whitish-yellow crystals in 30-40% yield (Scheme 5.6).11
Compound 4 was deprotected using 6 M NaOH (50 mL) at 100 °C overnight. The
solution was extracted with CHCl3/iPrOH (1/1, v/v, 100 mL × 3) and the organic phase
was combined and dried over anhydrous Na2SO4.11 The solution was ﬁltered and
concentrated by rotary evaporation. The excess of iPrOH was removed by repeated
washing with hexanes and compound 5 was obtained as yellow oil in 80% yield. The
mono-protection

of

AEE

(compound

6)

with

trifluoroacetate

derivative

was

accomplished using basic conditions.11 1H NMR (400MHz, CDCl3): δ 9.08 ppm (br. s,
CF3CONHCH2CH2OC(CH3)2OCH2CH2-NH2),
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7.31

ppm

(br.

s,

CF3CONHCH2CH2OC(CH3)2OCH2CH2-NHCOCF3),
CF3CONHCH2CH2OC(CH3)2OCH2CH2-NH2,

3.59
HE),

ppm

3.44

ppm

(s,
(s,

CF3CONHCH2CH2OC(CH3)2OCH2CH2NHCOCF3, HA, HA’, HB, HB’), 2.78 ppm (s,
CF3CONHCH2CH2OC(CH3)2OCH2CH2-NH2,
CF3CONHCH2CH2OC(CH3)2OCH2CH2-NH2),

HD),
1.27

1.77

(br.
ppm

s,
(s,

CF3CONHCH2CH2OC(CH3)2OCH2CH2NHCOCF3, HC, HC’). Refer to Figure 5.1 for
proton labeling.

Scheme 5.6. Synthesis of mono-protected pH-responsive initiator (AEE).
5.2.3 Synthesis of pH Responsive Diblock Copolypeptoids (AEE-PNMeOEt-bPNPgG)
In the glovebox, methoxy ethyl-NCA (M1) (55 mg, .346 mmol, [M1]0 = 0.4 M) was
dissolved in anhydrous THF (865 L). A predetermined volume of monoprotected AEE
initiator, compound 6, in a THF stock solution (34.6 μL, 7 μmol, 250 mM,
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[M1]0:[CF3AEE]0 = 50:1) was added to the monomer solution via syringe. Polymerization
was allowed to proceed for 24 h at 50 ºC under a nitrogen atmosphere. Aliquots of the
reaction mixture were taken and monitored for monomer conversion by FT-IR. Upon
completion of the first polymer block the analogue was end capped using acetic
anhydride in an equivalent amount to initiator before precipitation with excess hexane.
The molecular weight analysis of AEE-PNMeOEtG following precipitation was
conducted by size exclusion chromatography. Next, the initial polymer was stirred in a
10% sodium hydroxide solution in methanol for 10 min to remove the trifluoroacetate
protective group prior to the sequential addition of propargyl-NCA to the polymerization
for generation of the second polymer block. Under nitrogen, propargyl-NCA (M2) (24
mg, .173 mmol, [M2]0 = 0.1 M) was added to AEE-PNMeOEtG re-dissolved in
anhydrous THF (173 L) and stirred at 50 ºC for an additional 18 h. Complete monomer
conversion was monitored by FT-IR before the polymer chain end was capped with
acrylic anhydride. Following precipitation with excess hexane, the final block
copolymer’s composition and molecular weight was analyzed by 1H NMR spectroscop
(Figure S5.1) and SEC method (Table 5.1). 1H NMR (400 MHz, CDCl3), δ ppm:
6.35−6.15 (m, −COCH=CH2, HN), 5.83−5.35 (br. m, −COCH=CH2, HO), 4.43−4.20 (br.
m, −COCH2N−, HB, HK), 3.50−3.27 (br. m, −CCH2N−, −N(CH2)2OCH3, −N(CH2)2OCH3,
−CCH2N−, HC-HE, HL), 2.43−2.30 (br. m, HC≡CCH2N−, HM), 2.10−2.01 (br. s,
CH3COCN−, HA), 1.31 (br. m, −NHCH2CH2OC(CH3)2OCH2CH2NH−, HH). Refer to
Figure 5.2 for proton labeling.
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5.2.4 Synthesis of Cationic pH-Responsive and Non-pH Responsive Block
Copolypeptoids
Post-polymerization modification of the pH responsive diblock copolypeptoids
with 6-azidohexane guanidinium for their positively charged derivatives was achieved by
CuAAC chemistry as previously reported in chapter 3. The cationic polypeptoids were
purified by treatment with EDTA to remove copper salts followed by extensive dialysis
against DI water. Upon lyophilization, all polymers were obtained as white to pale green
powders in good yield (60-96%) with copper ion content in the sub-10 ppm range as
determined by the atomic absorption analysis. The copper ion content is significantly
lower than the concentration threshold that would otherwise cause potential copper ioninduced cytotoxicity.15 Cationic block copolymers were characterized by

1

H NMR

spectroscopy (Figure 5.4). 1H NMR (400 MHz, D2O), δ ppm: 8.01-7.95 ppm (br. m,
−C=CHN−,

HM),

4.69-4.18

[(br.m,−COCH2N−,−CCH2N−,−CONHCH2CH2OC(CH3)2OCH2CH2NHCO−,−CONHCH2C
H2OC(CH3)2OCH2CH2NHCO−, −NCH2(CH2)5NHCNH3, HB, HF, HG, HI, HL, HN)], 3.822.92 [(br. m, −CCH2N−, −N(CH2)2OCH3, −N(CH2)2OCH3, −NCH2CH2(CH2)4NHCNH3,
−N(CH2)4CH2CH2NHCNH3,

HC-HE,

HO,

HR)],

2.31-2.23

(br.

t,

CH3CON−,

−N(CH2)5CH2NHCNH2, HA, HS), 1.81-1.23 [(br. m, −N(CH2)2CH2(CH2)3NHCNH3,
−N(CH2)2(CH2CH2)(CH2)2NHCNH3,−N(CH2)4CH2CH2NHCNH3,−CONHCH2CH2OC(CH3)
2OCH2CH2NHCO−,

HP, HQ ,HH)]. Refer to Figure 5.6 for proton labeling.

In the glovebox, N-methoxy ethyl-NCA (M1) (86 mg, 0.74 mmol, [M1]0 = 0.4 M)
was dissolved in anhydrous THF (1.9 mL). A known volume of BnNH2/THF stock
solution (168 μL, 11 μmol, 63.2 mM, [M1]0:[BnNH2]0 = 40:1) was added using a syringe.
Polymerization was allowed to proceed for 24 h at 50 ○C under a nitrogen atmosphere.
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Aliquots of the reaction mixture were taken and analyzed for conversion by FT-IR and
molecular weights by SEC. An THF solution (2.5 mL) containing N-propargyl-NCA (M2)
(23 mg, 0.11 mmol, [M2]0 = 0.4 M, [M2]0:[BnNH2]0 = 10:1) was added into the above
reaction mixture, which was heated at 50 ○C for additional 24 h to reach complete
conversion. The polymer product was precipitated by the addition of cold hexanes and
collected by filtration. Following filtration, the polymer was washed with ample hexanes
to remove any unreacted monomers or homopolymers, and dried under vacuum (45
mg, 63% yield). The degree of polymerization (DP) of PNMeOEtG and PNPgG blocks
was determined by 1H NMR spectroscopy (Figure S5.2). 1H NMR (400 MHz, CD3CN), δ
ppm: 7.31−7.27 ppm (br m, −C6H5, HA), 4.80-4.16 (br. m, −COCH2N−, −CCH2N−, HC,
HG, HH), 3.48-3.25 [(br. m, −CCH2N−, −N(CH2)2OCH3, −N(CH2)2OCH3, HD, HE, HF)],
2.75-2.25 (br. m, HC≡CCH2N−, HI). Refer to Figure 5.5 for proton labeling.
Post-polymerization

modification

of

the

non-pH

responsive

diblock

copolypeptoids with 6-azidohexane ammonium (127) or 6-azidohexane guanidinium
(126) was achieved by CuAAC in the same manner that was used to obtain positively
charged homopolymers and random copolymers discussed in chapters 3 and 4. The
cationic polypeptoids were purified by treatment with an aqueous solution of EDTA (9.9
mM, 2 mL) to remove copper salts followed by extensive dialysis against DI water. Upon
lyophilization, all polymers were obtained as white to pale green powders in good yield
(60-96%) with copper ion content in the sub-10 ppm range based on the atomic
absorption analysis, which was significantly lower than the concentration threshold that
would otherwise cause potential copper ion-induced cytotoxicity. 1H NMR (400 MHz,
D2O), δ ppm: 8.05-8.01 ppm (br m, −C=CHN−, HI ), 7.23−7.19 ppm (br m, −C6H5, HA),
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4.70-4.33 (br. m, −COCH2N−, −CCH2N−, HC, HG, HH), 3.86 (s, −N(CH2)5CH2NH3), HO),
3.46 (s, −NCH2(CH2)5NHCNH3, −NCH2CH2(CH2)4NHCNH3, HJ, HK), 3.56-3.09 [(br. m,
−CCH2N−,

−N(CH2)2OCH3,

−N(CH2)2OCH3

,

HD-HF)],

1.80-1.26

[br.

m,

(−N(CH2)2CH2(CH2)3NH3, −N(CH2)2 (CH2CH2)(CH2)2NH3, −N(CH2)4CH2CH2NH3), HLHN]. Refer to Figure 5.7 for proton labeling.
5.2.5. Copolypeptoid/DNA Polyplex Preparation and Characterization
Cationic polypeptoids and pCMV-Luc were dissolved in PBS water at 1 mg/mL
and 0.1 mg/mL, respectively, and mixed at various polypeptoid/DNA weight ratios. The
mixture was vortexed for 10 s and further incubated at 37 oC for 30 min to allow
complete formation of the polyplexes. To qualitatively evaluate the DNA condensation
by the polypeptoids, a gel retardation assay was conducted. Briefly, freshly prepared
polyplexes were loaded in 1% agarose gel followed by electrophoresis at 100 V for 45
min. To quantitatively determine the DNA condensation level, the ethidium bromide (EB)
exclusion assay was adopted. EB solution was mixed with DNA at the DNA/EB weight
ratio of 10:1, and was incubated at room temperature for 1 h. Cationic polypeptoids
were then added to the mixture at various polypeptoid/DNA ratios, before further
incubation at room temperature for 30 min. Quantification of all polyplexes’ fluorescence
intensity was carried out by spectrofluorimetry (λex = 510 nm, λem = 590 nm). A pure EB
solution and the DNA/EB solution without any polypeptoids were used as negative and
positive controls, respectively. The DNA condensation efficiency (% DNA condensed)
was defined as the following:

DNA condensation efficiency (%) = (1 −
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F − FEB
) × 100
F0 − FEB

Where FEB, F, and F0 denote the fluorescence intensity of pure EB solution, DNA/EB
solution with polypeptoids, and DNA/EB solution without any polypeptoids, respectively.
5.2.6. Critical Micelle Concentration (CMC) Measurement of Copolypeptoid/DNA
Polyplexes
The critical micelle concentration experiment for polyplexes was carried out using
pyrene as a fluorescence probe. Fresh stock solutions of copolymer/DNA polyplexes
were prepared at 0.1mg/mL. Pyrene was dissolved in acetone at 1 mg/mL. The
concentration of copolymer/DNA polyplexes was varied from 1.010-6 to 0.3 mg/mL by
serial dilution with ultrapure water while the concentration of pyrene was fixed at 0.6 μM.
The mixture was incubated at 37 oC overnight and acetone was removed for another 4
h. The fluorescence spectra were recorded using the microplate reader with the
excitation wavelength of 330 nm. The emission fluorescence at 372 and 383 nm was
monitored. The CMC was estimated as the inflection-point when extrapolating the
intensity ratio I372/I383 at low and high concentration regions.
5.2.7. In Vitro Transfection
HeLa cells were seeded on 96-well plates at 2 × 104 cells/well and cultured in
DMEM containing 10% FBS for 24 h. The medium was replaced by opti-MEM (100
μL/well), into which polyplexes were added at 0.3 µg DNA/well. After incubation at 37 °C
for 4 h, the medium was replaced by DMEM containing 10% FBS, and cells were further
incubated for another 20 h. Luciferase expression level was determined in terms of
luminescence intensity using the Bright-Glo Luciferase assay kit (Promega), and the
cellular protein level was determined using the BCA kit (Pierce). Results were
expressed as relative luminescence unit (RLU) associated with 1 mg of pCMV-Luc
cellular protein (RLU/mg protein). To evaluate the transfection efficiency of polyplexes in
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the presence of serum, cells were incubated with polyplexes in DMEM supplemented
with 10% FBS for 4 h. Then the medium was replaced by fresh DMEM containing 10%
FBS and cells were further incubated for another 20 h before measurement of luciferase
expression levels as described above.
5.2.8. Cytotoxicity Studies
HeLa cells were seeded on 96-well plates at 2 × 104 cells/well and cultured for 24
h. The medium was replaced by opti-MEM (100 μL/well) into which free polypeptoids at
various concentrations or polyplexes at 0.3 μg DNA/well and various polypeptoid/DNA
weight ratios were added. After incubation at 37 °C for 4 h, the medium was replaced by
DMEM containing 10% FBS and cells were further incubated for another 20 h. Cell
viability was then evaluated by the MTT assay. Cells without polypeptoid or polyplexes
treatment served as the control and results were represented as percentage viability of
control cells.
5.3. Results and Discussion
5.3.1 Synthesis of Mono-protected pH-responsive Initiator (AEE) and Cationic pH
Responsive and Non-pH Responsive Diblock Copolypeptoids
Synthesis of cationic block peptoid copolymers which contain a pH responsive
linker has been investigated. As a result, the mono-protection of pH sensitive AEE was
accomplished by means of a multistep synthetic route (Scheme 5.6). Attempts at the
selective protection of the diamine under basic conditions with a trifluoroacetate yielded
the desired mono-protected and bis-protected product in an inseparable mixture as
illustrated in 1H NMR spectrum (Figure 5.1). The mixture was the statistical result of the
reaction. The relative integration of protons for the mono to bis protected diamine was
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used to determine the relative amount of each species by 1H NMR analysis (peak labels
E, C and C’ of Figure 5.1).

-C, C’
A, A’,
B, B’

D
-NH

-NH

E
-NH2

Figure 5.1. 1H NMR spectrum of mono-protected AEE amine initiator in CDCl3.
The primary amine-mediated ROP of Pg-NCA and MeOEt-NCA was used to
obtain neutral block copolypeptoid precursors bearing the pH responsive linker
(Scheme 5.4). For pH responsive diblock copolymer precursors, where the neutral
hydrophilic methoxy ethyl content was varied, the total degree of polymerizations DP =
50 and DP = 75 were targeted. After being synthesized their experimentally determined
compositions were determined by 1H NMR analysis and summarized in Table 5.1. The
block copolypeptoid composition was determined using the integrations of methyl
protons of PNMeOEtG segments and terminal alkyne proton of PNPgG segments
relative to the methyl protons in acetal end group in 1H NMR spectra (Figure 5.2). The
determined final chain lengths for unmodified pH responsive copolymers appeared to
correspond well with initially targeted [M]0:[I]0 ratios. SEC analysis revealed PNMeOEtG
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homopolymer precursors with relatively narrow polydispersities, which characteristically
suggested minimal molecular weight distribution and good control over ROP with the pH
responsive initiator. However, an increase in PDI was observed following generation of
the PNPgG block, presumably due to propargyl’s innate aggregation behavior in organic
solvent. According to Figures 5.3 and 5.4 SEC chromatograms suggested that the
diblock copolymer precursors did not suffer from any chain cleavage during the multistep synthetic route used to in final polymer chain lengths.

Figure 5.2. Representative 1H NMR spectrum of neutral pH-responsive block
copolypeptoid precursor (AEE-PNMeOEtG-b-PNPgG) in CDCl3.
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Table 5.1. Molecular weight parameters of neutral block copolypeptoid precursor (AEEPNMeOEt-b-PNPgG).
Sample [M]o:[N]o:[I]o DP
#
(1H NMR)

Mn
(SEC)a
kg∙mol -1

Mn (SEC)b
kg∙mol -1

PDI
(SEC)a

PDI
(SEC)b

Percent
Yield

128

25:25:1

m= 23 n= 31 5.78

6.80

1.09

1.30

100%

129

50:25:1

m= 51 n= 22 8.29

8.83

1.23

1.76

75%

a

Mn and PDI of PNMeOEt block was determined using a dn/dc of 0.0633mL∙g-1.

b

Mn and PDI of AEE-PNMeOEt-b-PNPgG block of copolymers were determined using
polystyrene standards.

Figure 5.3. SEC chromatograms of the neutral pH-responsive block copolypeptoid
precursor (AEE-PNMeOEt25-b-PNPgG25).* Indicates elution of LiBr/DMF solvent.
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Figure 5.4. SEC chromatograms of the neutral pH-responsive block copolypeptoid
precursor (AEE-PNMeOEt50-b-PNPgG25) copolymer precursors. * Indicates elution of
LiBr/DMF solvent.
Scheme 5.5 illustrates the synthetic route to prepare non-pH responsive cationic
diblock copolymers. The neutral block copolypeptoid precursors (PNMeOEtG-bPNPgG) have been similarly prepared as the one to the pH-responsive cationic block
copolypeptoid and characterized via 1H NMR spectroscopic analysis prior to CuAAC
functionalization to introduce the cationic sidechain (Table 5.2 and Figure 5.5). For the
non-pH responsive block copolymer precursor, a total degree of polymerization (DP) of
50 was targeted (Table 5.2). The block copolymer compositions determined from 1H
NMR analysis are in good agreement with targeted [M]0:[I]0 ratios, suggesting that the
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polymerization occurs in a controlled manner (Figure 5.3). The molecular weight
distribution (PDI) for the non-pH responsive block copolypeptoid precursors (PNMeOEtb-PNPgG) were not determined due to the malfunctioning of the SEC instruments at the
time.

C, G, H
D, E, F

I

A

Figure 5.5. 1H NMR spectrum of non-pH responsive neutral block copolypeptoid
precursor (PNMeOEtG-b-PNPgG) in CD3CN.

Table 5.2. Molecular weight parameters of neutral non-pH responsive block
copolypeptoid precursor (PNMeOEt-b-PNPgG) and the cationic non-pH responsive
block copolypeptoid.
Copolymer

[M]o : [N]o: [I]o

Chain length before Chain length after Percent Yield
CuAAC (1H NMR)
CuAAC (1H NMR)

126

40:10:1

m= 37 n= 12

m= 25 n= 10

89%

127

40:10:1

m= 37 n= 12

m= 31 n= 11

92%

The conjugation of cationic sidechains to the polypeptoid precursors were
conducted using CuAAC chemistry. Both pH-responsive and non-pH responsive block
copolypeptoids were found to be soluble in common organic solvents (e.g. chloroform,
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THF) but insoluble in water. The hydrophobic nature of the propargyl side chains is
likely to be responsible for the observed solubility property. Upon conjugation with
cationic moieties, resulting polypeptoids became water soluble. In all cases successful
conversion of neutral block copolymer precursors into cationic block copolypeptoids
was evidenced by the complete disappearance of the terminal alkyne proton of
propargyl group at 2.51 ppm and appearance of the triazole proton at 8.0 ppm in the 1H
NMR spectra, suggesting that the sidechain derivation was quantitative (Figures 5.6 and
5.7). Whereas the determination of the final composition of the non-pH responsive
cationic diblock copolypeptoids was feasible by 1H NMR analysis (Table 5.2), the
overlap of the polymer peaks with that of AEE initiating moieties in the 1H NMR spectra
prevented the composition for the pH responsive cationic copolypeptoid to be
unambiguously determined. One possible solution to this issue is to use acid to trigger
to cleavage of the cationic block copolymers. The resulting neutral segment
(PNMeOEtG) can be independently analyzed by the SEC method (in LiBr/DMF solvent)
to determine the chain length, which will allow us to deduce the chain length of the
cationic segment in the cationic block copolymer.
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D2O
B, F,
G, I,
L, N

C, D,
E, O,
R

* residual dioxane

*
P, Q, H
A, S

M

Figure 5.6. Representative 1H NMR spectrum of pH-responsive cationic block
copolypeptoid (AEEPNMeOEt-b-PNPG) in D2O.

D2O
*, O

C, G,
H

I

J, K

D, E, F

* residual dioxane

L, M, N

A

Figure 5.7. 1H NMR spectrum of non-pH responsive cationic block copolypeptoid
(PNMeOEt-b-PNPG) in D2O.
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5.3.2 Characterization of Cationic Block Copolypeptoid/DNA Polyplexes
Each cationic diblock copolypeptoid was qualitatively assessed for their capability
to condense DNA via the gel retardation assay (Figure 5.6). All polymers were able to
completely condense DNA at varied polypeptoid/DNA weight ratios. Non-pH responsive
cationic block copolypeptoids derived from PNMeOEt-b-PNPgG (126, 127 in Table 5.2)
were able to condense DNA at polymer/DNA weight ratio ≥ 1. This is comparable to
cationic polypeptoid homopolymers and random copolymers previously investigated
(chapter 3 and 4). By contrast, pH responsive cationic block copolypeptoids derived
from (AEE-PNMeOEt-b-PNPgG) (Table 5.1) complexed DNA at w/w ratios much higher
polymer/DNA ratios (≥ 10). To confirm these findings, a more quantitative EB exclusion
assay is required. Furthermore, zeta potential should be measured for the polyplexes
formed with the pH-responsive and non-pH responsive diblock copolymers in order to
obtain information about their surface charge characteristic. Due to differing chemical
compositions of the pH-responsive and non-pH responsive copolymers no direct
comparison of condensation profiles can be made.
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Figure 5.8. DNA condensation by cationic block copolypeptoids derived from the
PNMeOEt-b-PNPgG precursor (126, 127, Table 5.2) or AEE-PNMeOEtG-b-PNPgG
precursor (128, 129, Table 5.1) at various polymer/DNA weight ratios as evaluated by
the gel retardation assay. “N” represents naked DNA.

Block copolymers consisting of a hydrophilic and hydrophobic segment are
known to form micelles above a critical polymer concentration. For gene delivery
purposes CMCs can vary based on the polymeric structure.11-13 Polypeptoid/DNA
polyplexes based on the pH responsive and non-pH responsive cationic block
copolypeptoids and pCMV-Luc were also measured for a critical micelle concentration
(CMC) in deionized water at varying concentrations. Given the double hydrophilic nature
presented by polymer side chains within the copolymer design deviating from the
general description of what micelles are composed of, it was worthwhile to investigate
this aspect. DNA polyplexes with all polypeptoid block copolymers were prepared in
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water at the concentration 1 mgmL-1. To characterize the critical micellar concentration
(CMC), a series of aqueous solutions containing a constant concentration of pyrene and
varying concentrations of polypeptoid/DNA polyplexes were prepared and measured by
fluorescence spectroscopy in the 200-400 nm range with an excitation at = 370 nm.
Pyrenes are used as fluorophores that exhibits high fluorescence intensity in a
hydrophobic environment but low fluorescence intensity in a hydrophilic environment. 14
Plot of fluorescence maximum versus concentration revealed an inflection point where
the fluorescence intensity increases sharply. The polymer concentration at the inflection
point is defined as the CMC. Because two hydrophilic blocks are contained in my
copolymers used, the micellation process would be predominantly driven by
complexation between DNA and the cationic copolymer block. If the ionic domain
exhibited sufficient hydrophobic character, one would expect to see a difference in the
fluorescence intensity as a result of the partitioning of pyrene between the hydrophilic
and hydrophobic copolymer domains. It is clear in the 0.1- 1mg/mL concentration range,
no obvious trend of the fluorescent intensity was found with the concentration (Figures
5.9 A-D). Either no micelles are formed in this concentration range or the fluorescent
method based on pyrene is not suited for the determination of CMC for the micellation
of the cationic block copolymer with DNA. As the cationic block copolypeptoid
condenses with DNA, the micellar core may still be very hydrophilic due to the
abundance of charges. In this case, the fluorescent intensity of pyrene would not
change appreciably upon micelle formation. Further experiments are required to
determine the CMC in this system
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Figure 5.9. Log plot of the maximum fluorescence intensity (em = 372 & 383 nm) versus
polymer concentrations for cationic copolypeptoid/DNA polyplexes derived from:
PNMeOEt-b-PNPgG (126, 127, Table 5.2) and AEE-PNMeOEt-b-PNPgG (128, 129,
Table 5.1).
5.3.3. In Vitro Transfection of Polypeptoid/DNA Polyplexes
Using HeLa cells, pH-responsive and non-pH responsive cationic diblock
copolypeptoids were assessed for the gene delivery capability. As shown in Figure 5.10,
transfection efficiencies for pH-responsive and non-pH responsive block copolypeptoids
were considerably lower than PEI, more than ~3 orders of magnitude respectively. In
comparison with copolymers containing terminal guanidinium groups, the commercial
vector outperformed 126, 128, and 129 by up to 6 orders of magnitude (Figure 5.10 A,
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C, D). Though varying the polypeptoid/DNA weight ratio (w/w ratio) of the block
copolypeptoids did improve transfection by 1-2 orders overall, efficiencies were still not
comparable to that achieved with PEI. However, a trend was observed for the three
guanidinum samples upon increasing w/w ratios, with slightly higher efficiencies
produced in each case (Figure 5.10 A, C, D). Gene delivery for primary amine bearing
copolypeptoid, 127, yielded efficiencies that were also several orders lower (~4 orders)
than PEI (Figure 5.10 B). Varying w/w ratios appeared not to have any influence on the
transfection profile of 127 as seen with copolymers bearing guanidinum end groups. In
terms of transfection performance, no direct comparison can be made between the pHresponsive and non-pH responsive copolypeptoids given their different polymer
compositions.
As mentioned in chapter 3, the presence of hydrophobicity in addition to charge
is critical to enhanced transfection efficiency of polypeptoids. Findings from gene
delivery experiments in this work highly suggest that a lack in one or both of these
aspects lead to the consequence of poor transfection. In our earlier studies higher
transfection efficiencies were generated for copolymers comprised of hydrophobic side
chains in comparison to their corresponding homopolymer as the result of increased
membrane activity.9 In the case for all diblock copolymers, despite the presence of a
charged segment that can complex with DNA, the shielding of the polyplex by the
hydrophilic poly(N-methoxyethyl glycine) (PNOMEG) segments may have contributed to
the poor transfection efficiencies (Figures 5.10). The ability of PNOMEG to act as an
anti-fouling agent has been previously demonstrated by members of our group.16 In
addition, another factor which may have led to low transfection is the significantly
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reduced net positive charge on the surface of the polyplexe micelles due to the
shielding by PNOMeG segments. Measurements of zeta potential of the polyplex
micelles at different w/w ratios should shine lights on the relative strength of surface
charges.

Figure 5.10. Cell transfection of pCMV-Luc in DMEM using pH-responsive cationic block
copolypeptoid derived from PNMeOEt-b-PNPgG (126, 127, Table 5.2) and AEEPNMeOEt-b-PNPgG (128, 129, Table 5.1) as gene carriers.

5.3.4. Cytotoxicity of Cationic Block Copolypeptoid/DNA Polyplexes
The cytotoxicity of polyplexes based on pH-responsive and non-pH responsive
cationic diblock copolypeptoids were evaluated in HeLa cells under serum-free and
serum containing conditions. As shown in Figure 5.11, polyplexes formed with non-pH
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responsive samples displayed cytotoxicity profiles with very differing cell viability
percentages. In DMEM (serum-free) (Figure 5.11, A) and DMEM/10% FBS (serumcontaining) (Figure 5.11, B) polyplexes generated with 126 (guanidinum end group)
exhibited cell viability percentages significantly higher than 127 (ammonium end group),
by ~35% respectively. This trend was also observed at increased polypeptoid/DNA
weight ratios (Figure 5.11). The best toxicity profiles were displayed by polyplexes
based on pH responsive copolymers 128 and 129, with cell viability percentages
reaching greater than 80%. In the presence of increasing w/w ratios (up to 30:1)
exceptional viability was retained with 128 under both serum-free and serum containing
conditions (Figure 5.11). In serum-free and serum-containing media, weight ratios
higher than 20:1 led to a decline in cell viability for 129, 20% at 25:1 and 35% at 30:1
respectively. The cell viability for polyplexes made with pH-responsive and non-pH
responsive diblock copolypeptoids was observed in both serum-free and serum
containing conditions (Figure 5.11). However, a direct comparison of cytotoxicity profiles
for the pH-responsive and non-pH responsive cationic copolypeptoids cannot be made
due to their dissimilar compositions.
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Figure 5.11. (A) Percentage HeLa cell viability after being cultured with polyplexes
formed with cationic block copolypeptoid derived from AEEPNPgG-b-PNMeOEtG (128,
129, Table 5.1) or PNPgG-b-PNMeOEtG (126, 127, Table 5.2) in DMEM or (B) in
DMEM/10% FBS for 4 h and characterized by MTT assays.

5.4. Conclusion
In this work, pH responsive cationic block copolypeptoids have been synthesized
by sequential ring-opening polymerization of N-methyoxyethyl NCA and N-propargyl
NCA monomers using a mono-protected pH sensitive primary amine initiator and
subsequent CuAAC chemistry to conjugate cationic moieties to the sidechains of
poly(N-propargyl glycine) segment. The resulting cationic block copolypeptoids have
been characterized by a combination of

1

H NMR and SEC method and further

evaluated for their gene delivery capabilities in serum-free and serum containing media.
While the polyplexes based on the pH responsive cationic block copolypeptoids
exhibited good cytocompatibility with HeLa cells, they exhibited significantly reduced in
vitro transfection relative to PEI under serum free condition. Additional experiments are
required to fully understand the origin of the reduced gene transfection performance.
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CHAPTER 6. SYNTHESIS, CHARACTERIZATION, AND RING-OPENING
POLYMERIZATION OF N-THIOCARBOXYANHYDRIDE MONOMERS
6.1. Background and Introduction
Ring-opening polymerization of N-carboxyanhydride (NCA) monomers is widely
used for the syntheses of polypeptides and polypeptoids.1-5 For certain monomers such
as N-allyl and N-ethyl NCAs, this method can be unreliable due to the monomer’s
instability and tendency to undergo spontaneous polymerization.6 In addition,
purification of NCAs must be performed under moisture-free conditions such as by dry
solvent column chromatography, distillation, or vacuum sublimation, making the access
of pure monomer in large quantities challenging. As a result, there is a strong interest to
investigate more stable and robust monomers that can be used for polypeptides and
polypeptoid synthesis.

Figure 6.1. Structure of NCA vs. NTA monomer.
Amino acid derived N-thiocarboxyanhydrides (NTAs) (Figure 6.1) were first
investigated as a substrate for aqueous phase synthesis of polypeptides.6 NTAs were
investigated as an substrate for polymerization by Kricheldorf in 1974. These early
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studies showed that polymerization of NTAs tend to terminate at lower conversions
relative the polymerization of the corresponding NCAs, producing polypeptides with
significantly reduced polymer molecular weights.7,8 Polymerization of NTAs was
revisited by Kricheldorf and coworkers via the polymerizations of sarcosine, DLphenylalanine, and DL- using primary amine initiators.9 The observed molecular weights
for the polymers obtained from the ROPs of NTAs were considerably lower due to low
conversion. Quantitative conversions in the polymerization reactions were only reached
in the case of the ROP of sarcosine-NTA at the [M]0 : [I]0 = 20:1.
Ling and coworkers have recently demonstrated the controlled ROP of Nsubstituted glycine NTAs using rare earth borohydrides (RE) as initiators to produce
high-MW hydrophilic and hydrophobic polypeptoids.10 In this study sarcosine-NTA (SarNTA) and N-butylglycine NTA (NBG-NTA) were investigated. Among RE-(BH4)3(THF)3
compounds (RE = Sc, Y, La, Nd, Dy, or Lu) that have been investigated, the
borohydride complexes containing “Y” in the case of Sar-NTA and “Lu” in the case of Nbutylglycine exhibited the best polymerization control. It was shown that size of atomic
radii and electronic structure of RE metals greatly influenced polymerization reactivity.
For the first time, polysarcosines (PSars) with Mns higher than 10 kDa were achieved by
the polymerization of Sar-NTA in good yields (>90%). PNBGs with Mns up to 10.8 kDa
were also obtained by the polymerization of Bu-NTA, but with a slight decrease in yields
(75-65.3%). In spite the success of using metal hydride in the ROP of NTAs, concerns
about toxicity of residual metals in resulting polymers that may limit the biomedical
applications has motivated the search of new organic initiator/catalyst systems for NTA
polymerization. Ling et al. recently reported a controlled ROP of Sar-NTA using primary
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amine-terminated PEG as macroinitiators.11 Subsequently, the scope of NTAs that can
be successfully polymerized in a controlled fashion using primary amine initiators has
been further expanded to include Et-NTA and Bu-NTA.7,8 Degrees of polymerization
(DPs) larger than 150 were obtained for PNBGs and high DP up to 287 and 262 were
reached for poly(N-ethyl glycine) and polysarcosine respectively.
6.2. Ring-opening Polymerization of R-NCAs or R-NTAs by the Normal Amine
Mechanism (NAM).
Commonly referred to as the normal amine mechanism (NAM), this process
takes advantage of the electrophilic character of NCAs. In this mechanism, organic
molecules with sufficient nucleophilicity (i.e., water, alcohol, primary amine, secondary
amines, thiols) act as initiators to initiate the polymerization of the R-NCA monomer in a
regioselective manner by ring-opening addition to the C5 carbonyl followed by
decarboxylation to generate the initiating species bearing a primary amino terminus,
from which enchainment ensues by the same sequence of events. The regioselectivity
for the nucleophilic addition of amine to C5 over C2 carbonyl is enhanced for R-NCAs
bearing electron donating N-substituents relative to NCAs bearing the N-H, further
reducing the probability of termination by this pathway relative to propagation.
Secondary amines tend to be less nucleophilic than the primary amines which in turn
warrants faster initiation relative to propagation, a critical criterion for living
polymerization. Due to the reduced electrophilicity of the C5 carbonyl in R-NTA relative
to R-NCA and more stable thiocarbamic acid propagating intermediates, nucleophilic
addition of amines to R-NTAs and decarboxylation relative to those of R-NCAs
precedes

much

slower.

To

date,

several
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N-substituted

glycine-derived

N-

thiocarboxyanhydrides (i.e., Me-NTA, Et-NTA and Bu-NTA have only been investigated
as substrates for polymerization using primary amine initiators.
6.3. Ring-opening Polymerization by the Activated Monomer Mechanism (AMM).
In addition to polymerization by the NAM pathway, NCAs can also undergo ROP
via a different mechanism commonly known as the activated monomer mechanism
(AMM) (Scheme 6.1). Initially in this process the deprotonation of NCAs by an organic
base, typically primary or secondary amines, produces the anionic substrate 1, a.k.a.,
the activated monomer. Once “activated” the negatively charged monomer reacts with
another NCA at the C5 carbonyl position by nucleophilic ring-opening addition followed
by decarboxylation to form the acylated NCA initiating species 3 (Scheme 6.1).12,13
Subsequent chain propagation involves further addition of NCA anions to the acylated
NCA species 4. Faster propagation relative to initiation takes place as a result of the
increased electrophilicity of 4 compared with NCAs and facile decarboxylation from
more electrophilic carboxyamide intermediate 5 in contrast to 2. Unlike with the NAM
pathway, only NCA monomers bearing the N-H proton can participate in ring-opening
polymerization by AMM. In general, amines with enhanced basicity and reduced
nucleophilicity (i.e., sterically hindered secondary or tertiary amines) tend to favor the
AMM for the polymerization of NCAs bearing the N-H proton.
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Scheme 6.1 Activated monomer mechanism (AMM) for the ROP of N-H bearing NCAs.

Given their labor-intensive synthesis and susceptible nature to spontaneous
polymerization, motivation for developing NTAs as alternatives to NCA monomers
continues to receive attention from the scientific community. Mechanistically, the
polymerization of NTAs should parallel those of NCAs except that carbonyl sulfide gas
is lost versus that of carbon dioxide as mentioned in sections 2.3.2 (Scheme 2.3) and
6.2. Research endeavors towards the ROP of Me-NTA have been explored previously
by members of our group. Several initiators including benzyl amine, an obvious choice
due to known instances that polypeptoids with predictable molecular weights can be
obtained from primary amine mediated ROP of R-NCAs via the normal amine
mechanism, and 1,1,3,3‑tetramethylguanidine (TMG), which have been previously
demonstrated to participate in the ROP of R-NCAs were screened. Of the specified
initiators investigated it was found that TMG performed the best in the ROP of MeNTA.14 From these studies polymerization reactions were observed to reach quantitative
conversion in 18 h, nearly threefold faster than previous reports (48 h). Furthermore,
polymerization reactions were carried out at ambient temperature versus 60 °C in
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previous reports. From molecular weight characterization data, it was found that
molecular weights increased with increasing monomer to initiator loadings, suggesting
that the ROP of Me-NTA exhibits living character.14 Polysarcosines with relatively
narrow PDIs (1.04-1.11) were also obtained.
The success of Me-NTA as a substrate for ROP scientifically has created
confidence that other NCA monomers which suffer from poor shelf-life (i.e. Allyl-NCA
and Ethyl-NCA) due to sensitivity to moisture and heat can be alternatively derived. Like
polysarcosine, polypeptoids produced from these two monomers can be used as
potential biomaterials due to their water solubility. My study on N-allyl NCAs has shown
that this monomer, existing as an oil at room temperature, is highly susceptible to
spontaneous polymerization. In view of the enhanced stability of NTA analogs, I set out
to investigate the synthesis, characterization, and polymerization of N-allyl Nthiocarboxyanhydride (Al-NTA) which will be discussed for the rest of the chapter. As
stated in chapter 2, the presence of an alkene group allows for introduction of new
functionalities to poly(N-allyl glycine) via thiol-ene chemistry, making it a desirable
platform to further diversify the polypeptoid structures towards various new technical
and biomedical applications.
6.4. Materials and Methods
6.4.1 General Considerations
All chemicals were purchased from Sigma-Aldrich and used as received unless
specified. All solvents are regular ACS grade solvents and used directly in the reactions
without any special purification step unless specified. 1H and

13

C{H} NMR spectra were

recorded on a Bruker AV-400 or AV-500 spectrometer. Chemical shifts in ppm were
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referenced relative to proton impurities or

13

C isotope of deuterated solvents (e.g.,

CDCl3, CD3CN, THF-d8). SEC-DRI analyses were performed with an Agilent 1200
system equipped with three Phenomenex 5 μm, 300 × 7.8 mm columns [100 Å, 1000 Å
and Linear(2)], Wyatt DAWN EOS MALS detector (GaAs 30 mW laser at λ=690 nm)
and Wyatt Optilab rEX DRI detector with a 690 nm light source. DMF containing 0.1 M
LiBr was used as the eluent at a flow rate of 0.5 mL∙min-1. The temperature of the
column and detector was 25 °C.
6.4.2 Synthesis of S-Ethoxythiocarbonyl Mercaptoacetic Acid (XAA).
The synthesis route is modified from a published procedure.15 NaOH (9.31 g,
23.3 mmol) was first dissolved in DI water (233 mL), followed by addition of chloroacetic
acid (22.02 g, 23.30 mmol) to afford a homogeneous solution. Potassium ethyl
xanthogenate (37.36 g, 23.31 mmol) was then added to the above solution. The mixture
was stirred at room temperature overnight, followed by acidification with concentrated
HCl to pH ~ 2-3. Next, the resulting cloudy mixture was then extracted with chloroform
(3 × 150 mL). The combined organic extract was dried over MgSO4 and concentrated
under vacuum. Excess hexanes (500 mL) was then added to the oily residue with
vigorous stirring to produce an off-white solid, which was collected by filtration and
washed with additional hexanes and dried under vacuum to afford the final product in
91% yield (Appendix Figure C.1).
6.4.3. Synthesis of Allyl N-thiocarboxyanhydrosulfide (N-Al NTA).
For the following synthesis, the N-Allyl glycine hydrochloride used was prepared
using the procedure reported for monomer synthesis in chapter 2 (Scheme 2.1). N-Allyl
glycine hydrochloride (12.5 g, 82.7 mmol), S-ethoxythiocarbonyl mercaptoacetic acid
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(14.9 g, 82.7 mmol) and NaOH (6.83 g, 6.83 mmol) were dissolved in 400 mL water and
reacted for 24 h at 25 ºC. Next the reaction mixture was acidified to a pH of 2 using
concentrated hydrochloric acid. The product N-ethoxythiocarbonyl-N-allylglycine (N-AlXAA) was then extracted several times with ethyl acetate (5 x 100 mL). The organic
phase was washed with aqueous citric acid (5 wt %) before concentrating under
reduced pressure and drying over MgSO4. The final product was directly used for
cyclization without further purification (Appendix Figure C.2).
To a round bottom flask N-Al-XAA (7.70 g, 37.9 mmol) was dissolved in
chloroform (300 mL) and cooled in an ice bath (Scheme 6.1). PCl3 (4.96 mL, 56.8 mmol)
was added dropwise in 15 min at 0 ºC. The reaction mixture was stirred for additional 10
min at 0 ºC before warming to room temperature for the duration of the reaction. After 4
h the reaction was washed by saturated solution of NaHCO3 (3 x 150 mL) and
deionized water, the chloroform solution was dried with MgSO4 and concentrated in
vacuum. The crude product was purified by flash column chromatography with ethyl
acetate and petroleum ether (1:3) to give the final product as a slightly viscous yellow oil
in 64.8% yield. HRMS-ESI (m/z): [M + H]+ calculated for C6H7NO2S 158.0281, found
158.0281. 1H NMR (400 MHz, CDCl3) δ (ppm): 5.81-5.76 (m, 1H, CH2=CHCH2N-), 5.345.27 (m, 2H, CH2=CHCH2N-), 4.16-4.13 (d, 4H, CH2=CHCH2N-, -NCH2CO-).

13

C NMR

(400 MHz, CDCl3) δ (ppm): 193.78, 164.48, 130.60, 120.03, 59.36, 46.45.
6.4.4. Ring-opening Polymerization of N-Allyl N-Thiocarboxyanhydride using
Benzylamine Initiator
A representative polymerization of Allyl NTA monomer was conducted as follows
(Scheme 6.2). Inside the glovebox, Allyl NTA (24.8 mg, 0.158 mmol) was dissolved in
anhydrous THF (0.284 mL) under nitrogen atmosphere. Predetermined volume of a
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stock solution of benzylamine initiator in THF (31.6 µL, 6 µmol, 250 mM) was added to
the above solution. The mixture was a clear, homogenous solution. The polymerization
was stirred at 60 ºC for 48 h. Monomer conversion was tracked by 1H NMR via sampling
a reaction aliquot. Isolation of polymers was achieved by precipitation with excess
diethyl ether, followed by centrifugation and decanting. Final polymer was vacuum dried
for a white solid (10.2 mg, yield: 67%). Characterization of polymer composition and
molecular weight was carried out by 1H NMR spectroscopy, SEC, and MALDI-TOF MS.
6.5. Results and Discussion
6.5.1 N-Allyl N-Thiocarboxyanhydride Monomer
The allyl NTA monomer (Figures 6.1, 6.2, and Appendix Figure C.3) was
synthesized

by

adapting

published

procedures2,7,8

and

purified

by

column

chromatography in air. Prior to polymerization further purification of the NTA monomer
using a DCM solution containing CaH2 was performed in order to rid any potential
residual HCl or other protic species produced during cyclization. It is worth mentioning
that the CaH2 treatment is highly necessary for the complete purification of the final
monomer for polymerization purposes. I have found that spectroscopically clean Al-NTA
monomers obtained by column chromatography without CaH2 treatment can result in
unsuccessful polymerizations.
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Scheme 6.1. Synthesis of N-Allyl NTA monomer.

C, D

B

A

Figure 6.2. 1H NMR spectrum of N-Allyl NTA in CDCl3.
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A
D

C

B
F

E

Figure 6.3. 13C {H} NMR spectrum of N-Allyl NTA in CDCl3.
N-thiocarboxyanhydrides are well-known for their enhanced stability and shelf life
under both ambient and inert atmospheres (e.g. nitrogen, argon) in contrast to NCAs.7
Compared with Al-NCA (Appendix Figure C.4), Al-NTA in its neat state is notably more
stable in air up to a week before any obvious monomer conversion is noted by FT-IR
spectroscopic analysis as shown in figure 6.4. The Al-NTA monomer has a
characteristic carbonyl C=O stretching band at 1795 cm-1 (Figure 6.4) allowing for the
conversion of the monomer to be readily monitored. In solution state (e.g., THF), AlNTA also exhibits enhanced stability towards air relative to the NCA analog (Appendix
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evidenced by the emergence of carbonyl stretching band at 1654-1697 cm-1 range
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(Figure 6.5).
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6.5.2. ROP of Allyl NTA with Organo-base Initiators.
Previously, several organo-bases including N-heterocyclic carbene (NHC), 1,8
diazabicycloundec-7-ene (DBU), and 1,1,3,3-tetramethylguanidine (TMG) have been
investigated by our group for the ROP of N-substituted NCAs.16-19 These initiators can
either initiate the zwitterionic ROP of N-substituted NCA in a controlled manner or serve
as activators for the alcohol based initiators via hydrogen bonding to mediate the
ROP.17 Because of these previous findings I am encouraged to explore the effect of
organo-bases in the ROP of NTAs.
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Scheme 6.2. Representative
Thiocarboxyanhydride monomer.

benzylamine

mediated

ROP

of

N-Allyl

N-

Initially benzylamine was examined as an initiator for the ring-opening
polymerization of NTA monomers (Scheme 6.2). It was found that benzylamine can
effectively initiate the polymerization of Al-NTA to produce poly(N-ally glycine) (PNAlG)
polymers in THF solvent at 60 oC. Under this standard condition various initial monomer
to initiator ratios ([M]0:[I]0= 25:1-300:1) were investigated in an effort to examine the
molecular weight control in the ROP of N-allyl NTA (Table 6.1). All reactions required 48
h to reach quantitative conversions, which are slower compared to ROP of the Al-NCA
analogs using primary initiators (Table 6.2 and Figure 6.6 B). MALDI-TOF MS analysis
of resulting low molecular PNAlG polymers from Al-NTA confirms that the
polymerization with benzylamine proceeds by the normal amine mechanism producing
polypeptoids bearing one benzylamide and one secondary amine chain end (Figure
6.8). In comparison to NCAs, the C5 carbonyl in the NTA monomer is less electrophilic
due to the reduced electronegativity of the sulfur atom, rendering it less reactive
towards nucleophilic addition. Furthermore, elimination of COS from the thiocarbamate
propagating intermediate is also slower than the carbamate species in the
polymerization of NCA analogs. SEC analysis of the resulting polymers (Figure 6.6 A)
exhibited either broad or multimodal distribution with Mn in the 4.2-12.5 kg/mol range
and PDIs in the 1.21-1.61 range (Table 6.1). While the polymer molecular weight (Mn)
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was found to increase with increasing [M]0:[I]0 ratio for PNAlGs obtained from Al-NTA
(Appendix Figure C.6), the absolute value of Mns has varying level of deviation from the
theoretical prediction based on a living polymerization. This MW outcome is dissimilar to
those obtained for polymers from Al-NCA (Appendix Figure C.7). Compared with Mns
for PNAlGs obtained from SEC values determined by 1H NMR were in disagreement,
being significantly lower as shown in Table 6.1. The sensitivity of NMR spectroscopy
proves highly useful in the structural elucidation of PNAlGs but is limited in terms of
determining accurate molecular weight dispersity (MWD). This is accredited to
linewidths increase as a consequence of larger molecules present which due to
stronger spin-spin relaxation, puts a maximum on the size obtainable by the particular
method. As a direct result, when molecules are too large the peaks overlap or become
so broad they become undetectable. SEC tends to provide more reliable information
about the true molecular weight dispersity (MWD), making it possible to evaluate the
level of control of ROP of NCA and NTA.
Table 6.1. Benzylamine initiated ring-opening polymerization of Al-NTA in THF.
[M]o:[I]o

Time (h)

Mn (theor.)
(kg/mol-1)

Mn
(kg/mol-1) a

Mn
(kg/mol-1) b

PDI b

Conv. % c

Percent
yield

25:1-THF

48

2.5

2.3

4.1

1.21

100%

52.6%

50:1-THF

48

4.9

4.0

6.8

1.21

100%

100%

150:1-THF

48

14.7

8.9

10.8

1.38

64%

50%

300:1-THF

48

29.2

12.9

12.5

1.61

38%

43.5%

(Table cont’d)

138

[M]o:[I]o

Time (h)

Mn (theor.)
(kg/mol-1)

Mn
(kg/mol-1) a

Mn
(kg/mol-1) b

PDI b

Conv. % c

Percent
yield

25:1-THF

48

2.5

2.3

3.8

1.26

100%

83.4%

50:1-THF

48

4.9

3.8

6.6

1.30

100%

65.8%

150:1-THF

48

14.7

8.2

9.6

1.41

58%

42%

300:1-THF

48

29.2

12.0

11.8

1.53

27%

35.7%

a.

Experimental chain length determined by integration of the terminal alkene peak relative to the benzyl
peaks in their respective 1H NMR spectra in CD3CN. b. Experimental molecular weight and polydispersity
indices were obtained from SEC-MALS-DRI system in 0.1 M LiBr/DMF solution using dn/dc of 0.0950
g/mol-1. c. Obtained via 1H NMR. All Polymerizations were done in THF at [.5M] at 60ᵒC.

B

A

Figure 6.6. A) SEC chromatograms of PNAlGs obtained by benzylamine mediated ROP
of Al-NTA under standard conditions (60 oC). B) SEC chromatograms of PNAlGs
obtained by benzylamine mediated ROP of Al-NCA under standard conditions (50 oC).
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CD3CN

e

b, c

d

a

Figure 6.7. 1H NMR spectrum of BnPNAlG in CDCN3.

Table 6.2. Molecular weight parameters
polymerization of Al-NCA at 50 oC in THF.

for

BnNH2

mediated

ring-opening

[M]o:[I]o

Time (h)

Mn (theor.)
(kg/mol-1)

Mn
(kg/mol-1) a

Mn
(kg/mol-1) b

PDI b

Conv. % c

Percent
yield

25:1-THF

18

2.5

1.7

1.5

1.09

100%

85.6%

50:1-THF

24

4.9

3.9

4.5

1.29

100%

100%

150:1-THF

24

14.7

12.5

7.7

1.18

100%

50%

300:1-THF

--

29.2

--

--

--

--

--

a.

Experimental chain length determined by integration of the terminal alkene peak relative to the benzyl
peaks in their respective 1H NMR spectra in CD3CN. b. Experimental molecular weight and polydispersity
indices were obtained from SEC-MALS-DRI system in 0.1 M LiBr/DMF solution using dn/dc of 0.0950
g/mol-1. c. Obtained via FTIR. All Polymerizations were done in THF at [.5M] at 50ᵒC.
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Figure 6.8. MALDI-TOF MS spectra of PNAlGs obtained by benzylamine mediated ROP
under standard conditions.
6.5.3. ROP of Allyl NTA with BnNH2/CH3COOH.
Recently, my group member demonstrated that the presence of weak acid such
as benzoic acid or acetic acid can improve the conversion during the ROP of aminoacid derived NTAs bearing N-H protons using benzylamine initiators. In addition, it was
also shown that polymerization afforded higher conversions when conducted with the
concurrent removal of COS under reduced pressure throughout the reaction. The
hypothesis is that the hydrogen bonding interaction between the weak acid and
thiocarbamate may accelerate the COS elimination relative to H2S elimination (which
results in termination), thus improving the polymerization conversion. In addition, COS
elimination could be the rate-limiting step in the polymerization of NTAs using primary
amine initiators. Inspired by this empirical finding, I set to investigate the effect of acetic
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acid on the polymerization of Al-NTA. While in the ROP of Al-NTA using primary amine
initiators, H2S elimination is not possible. However, the COS elimination is required for
the polymerization to proceed in a normal amine mechanism. It is entirely plausible that
the presence of hydrogen bond donor can accelerate the COS release.
I found that introducing acetic acid as a co-catalyst in 2-4 equivalents relative to
BnNH2 initiator in the ROP of Al-NTA ([M]0:[I]0= 25:1) significantly reduced the reaction
time required for full conversion from 48 h to less than 24 h (Table 6.3). Moderate to
quantitative conversions can also be obtained at room temperature with increasing
acetic acid loadings (Table 6.4). On contrary this trend is not observed for higher
[M]0:[I]0 ratios. Using standard conditions, at the [M]0 : [I]0 ratio of 50:1 the acid cocatalyzed (4 eq.) ROP of Al-NTA resulted in ~ 37% monomer conversion after 24 h
(Table 6.5). No monomer conversion was detected in the case of higher [M]0:[I]0 ratios.
In recollection of possible reasonings mentioned in the discussion pertaining to NAM, I
believe this incidence is attributed to the fast acid consumption that would occur in the
first circumstance. Under both standard and non-standard conditions, I detected that the
load amount of acetic acid influenced the polymerization Al-NTA. By using acid additive
the MW and polydispersity of PNAlGs analogues were closer to targeted Mns with
narrower distribution upon increased loadings (Tables 6.3 & 6.4).
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Table 6.3. Molecular weight parameters for BnNH2/CH3COOH mediated ring-opening
polymerization of Al-NTA at 60 oC in THF.
[M]o:[I]o:[HA]o Time (h)

Mn (theor.)
(kg/mol-1)

Mn
(kg/mol-1) a

Mn
(kg/mol-1) b

PDI b

Conv. % c

25:1:1

22

2.5

1.7

4.4

1.45

76.5%

25:1:2

22

2.5

1.9

5.4

1.62

100%

25:1:3

22

2.5

1.9

3.7

1.22

100%

25:1:4

22

2.5

1.9

3.8

1.18

100%

25:1:1

22

2.5

2.0

3.5

1.25

82%

25:1:2

22

2.5

1.9

3.8

1.14

100%

25:1:3

22

2.5

1.8

3.2

1.17

100%

25:1:4

22

2.5

2.0

3.7

1.17

100%

a.

Experimental chain length determined by integration of the terminal alkene peak relative to the benzyl
peaks in their respective 1H NMR spectra in CD3CN. b. Experimental molecular weight and polydispersity
indices were obtained from SEC-MALS-DRI system in 0.1 M LiBr/DMF solution using dn/dc of 0.0950
g/mol-1. c. Obtained via 1H NMR. All Polymerizations were done in THF at [.5M].
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Figure 6.9. SEC chromatograms of PNAlGs obtained by BnNH2/CH3COOH mediated
ROP under standard conditions (60 oC).

Table 6.4. BnNH2/CH3COOH- mediated ring-opening polymerization of Al-NTA at 23 oC
in THF.
[M]o:[I]o:[HA]o

Time (h)

Mn (theor.)
(kg/mol-1)

Mn
(kg/mol-1) a

Mn
(kg/mol-1) b

PDI b

Conv. % c

25:1:1

24

2.5

1.6

3.5

1.19

60%

25:1:2

24

2.5

2.2

3.2

1.24

77%

25:1:3

24

2.5

1.9

2.9

1.21

84%

25:1:4

24

2.5

2.2

3.8

1.10

88%

25:1:5

24

2.5

2.3

3.5

1.21

81%

25:1:6

24

2.5

2.0

4.1

1.12

100%

(Table cont’d)
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[M]o:[I]o:[HA]o

Time (h)

Mn (theor.)
(kg/mol-1)

Mn
(kg/mol-1) a

Mn
(kg/mol-1) b

PDI b

Conv. % c

25:1:1

24

2.5

2.1

4.5

1.21

89%

25:1:2

24

2.5

2.2

4.2

1.07

91%

25:1:3

24

2.5

2.3

6.2

1.17

100%

25:1:4

24

2.5

2.2

4.1

1.09

91%

25:1:5

24

2.5

2.3

7.1

1.10

59%

25:1:6

24

2.5

2.2

3.2

1.12

100%

a.

Experimental chain length determined by integration of the terminal alkene peak relative to the benzyl
peaks in their respective 1H NMR spectra in THF-d8. b. Experimental molecular weight and polydispersity
indices were obtained from SEC-MALS-DRI system in 0.1 M LiBr/DMF solution using dn/dc of 0.0950
g/mol-1. c. Obtained via 1H NMR. All Polymerizations were done in THF at [.5M].

Figure 6.10. SEC chromatograms of PNAlGs obtained by BnNH2/CH3COOH mediated
ROP at 23 oC.
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Table 6.5. BnNH2/CH3COOH mediated ring-opening polymerization of Al-NTA at 60 oC
in THF ([M]0 : [I]0 ratios 25-300).
[M]o:[I]o:[HA]o

Time (h)

Mn (theor.)
(kg/mol-1)

Mn
(kg/mol-1) a

Mn
(kg/mol-1) b

PDI b

Conv. % c

25:1:4

24

2.5

1.6

3.5

1.19

100%

50:1:4

24

2.5

1.7

1.9

1.10

37%

150:1:4

24

2.5

--

--

--

--

300:1:4

24

2.5

--

--

--

--

a.

Experimental chain length determined by integration of the terminal alkene peak relative to the benzyl
peaks in their respective 1H NMR spectra in THF-d8. b. Experimental molecular weight and polydispersity
indices were obtained from SEC-MALS-DRI system in 0.1 M LiBr/DMF solution using dn/dc of 0.0950
g/mol-1. c. Obtained via 1H NMR. All Polymerizations were done in THF at [.5M].

6.5.4. Interfacial ROP (iROP) of Allyl NTA with BnNH2
The interfacial ring-opening polymerization of NTAs using nonpolar solvents have
been previously demonstrated by members of our group. Polypeptides derived from the
iROP of α-amino-acid derived N-thiocarboxyanhydrides (NTAs) in hexanes or heptane
suspension using soluble primary amine initiators were successfully obtained under mild
conditions (50-80 ⁰C).20 Polymers of various molecular weight and low-to-moderate
molecular weight distribution could be attained with good control. Encouraged by the
success of this approach in generating well-defined polypeptides with good control, I
was prompted to examine the iROP of Al-NTA using benzylamine.
Benzylamine mediated iROPs of Al-NTA were performed in heptane at 23 ⁰C and
90 ⁰C at various M : I ratios. Compared with solution phase ROPs, iROPs of Al-NTA
require significantly longer time periods (7 days), with less than 100% monomer
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conversion reached in all cases for polymerizations conducted under heat (Appendix
Figure C.8). After several days no monomer conversion was observed for iROPs
performed at room temperature, indicating the important role of higher temperatures in
driving polymerizations to completion via COS elimination. The type of solvent used
also appears to have a major effect on the iROP of Al-NTA, resulting in low monomer
conversion as demonstrated by my group member. One plausible explanation for this
observed occurrence is the propagating chain’s inability to interact with remaining
monomer within the suspension due to a difference in solubilities. Another possible
reason for low monomer conversion is the fast consumption of initiator. Under both
circumstances the final polymer chain length would be limited as a result of loss of
reactivity.
6.6. Conclusion
The synthetic route and characterization of a new NTA monomer was
successfully demonstrated in this work. Al-NTA offers an air and moisture stable
alternative to its NCA counterpart, hence allowing for facile preparation under ambient
conditions on a multigram scale. Based on presented evidenced it is concluded that
conventional ring-opening polymerization of the NTA monomer with primary amine
initiators precede much slower than its NCA analogue under standard conditions. A
difference in electronic properties presented by each monomer’s heteroatom is primarily
responsible for this observed effect.
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CHAPTER 7: SUMMARY AND FUTURE WORK
Poly(α-peptoid)s have emerged as a class of peptidomimetic polymers that are
increasingly investigated in the fields of materials science and biomedical science.
Development of synthetic methods to increase the structural diversity of polypeptoids is
important for the further investigation of these polymers for various biomedical or
biotechnological applications. My research efforts focused on diversifying polypetopid
structure for different applications and developing new and facile synthetic method to
access polypeptoids that can be further derivatized to install other functional groups.
In Chapter 1, the idea of gene therapy was reviewed. Subjects relevant to the
practice were discussed including the associated disadvantages and disadvantages.
Challenges faced by current practices of gene therapy in this chapter served as
motivation for the completed work discussed in succeeding chapters.
In Chapter 2, the background and fundamentals of poly(-peptoids) have been
reviewed. Synthetic strategies used to generate oligomeric and polymeric polypeptoids
were discussed. It also highlighted the challenges that should be addressed to further
facilitate the development of polypeptoids. This section gave an overview of the
previous progress with polypeptoid-based functional materials as well as some
fundamental properties of polypeptoids.
In Chapter 3, the motivation, design and performance of cationic polypeptoids as
nonviral gene delivery both in vitro and in vivo was discussed. Transfection efficacy as a
correlation of various molecular parameters has been studied in order to determine
optimal molecular structural motif for gene transfection. A library of linear cationic
polypeptoids comprised of various chain lengths were obtained by a combination of
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primary amine-initiated ring-opening polymerization of propargyl-NCA and CuAAC
chemistry. Analogues bearing primary amine terminal groups were found to possess
excellent gene transfection efficiency under serum free and serum containing
conditions.
In Chapter 4, the capacity of cationic copolymers serve as a carrier for genetic
materials has been extended to RNA delivery to treat systemic inflammation. Random
copolymers containing guanidium terminal groups have been designed, synthesized
and characterized. Reduction of systematic inflammation in vitro and in vivo was
achieved using the cationic random copolypeptoids, further demonstrating the potential
of polypeptoids in the field of gene therapy. Given the difference of location and
biological processes involved in DNA (nucleus) and RNA (cytoplasm) delivery, the
generality of peptidomimetics is highlighted in this work.
The studies in Chapter 3 and 4 have revealed the generally reduction of
transfection efficiency of cationic polypeptoid carriers in serum-containing environment
presumably due to non-specific interaction of the polyplex particles with serum
components. In chapter 5, pH-responsive cationic diblock copolypeptoids bearing a
non-ionic and hydrophilic segment and a cationic segment has been designed and
synthesized to address this challenge. The polymer is expected to condense with
genetic materials to form micellar particles, thus shielding them from the challenging
environment in serum. The evaluation of pH-responsive and non-pH responsive block
copolymers regarding their DNA condensation capability and cytotoxicity has pointed to
potential limitations presented by these carriers for gene delivery. Critical micelle
concentration experiments also reveal apprehension about the micellar character of the
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diblock copolymers. Synthetic approaches that yield polypeptoids which exhibit
architecture without compromising transfection efficiencies will have a scientific impact
in the discipline of gene therapy.
During the course of my research, the need for polypeptoids that can be further
derivatized post-polymerization to increase structural diversity has become apparent. In
Chapter 6, the synthesis and characterization of a new N-Allyl N-thiocarboxyanhydride
(Al-NTA) monomer has been studied. NTA monomers are of growing interest due of
their enhanced stability against moisture and heat relative to their NCA analogs. While
Al-NTAs can undergo ring-opening polymerization in the solution phase using primary
amine initiators under relatively mild conditions, control over the molecular weight and
molecular weight distribution of the resulting polypeptoids pose an issue. Building from
research endeavors put forth in obtaining a well-controlled system, strategies such as
use of organic solvents with lower dielectric constants and other organo base initiators
toward development of controlled polymerization of Al-NTA under mild conditions to
prepare well-defined polypeptoids should be considered for future studies.
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APPENDIX A: SUPPLEMENTAL DATA FOR CHAPTER 3

Figure A.1. Representative 1H NMR spectrum of the polypeptoid polymer in CD3CN
obtained from grafting CPT to PNAlG polymer via radical thiol-ene chemistry.
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Figure A.2. 1H NMR spectrum of 2-(2-(2-hydroxyethoxy)ethoxy)ethane thioacetate in
CD2Cl2.
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Figure A.3.
CD2Cl2.

13

C NMR spectrum of 2-(2-(2-hydroxyethoxy)ethoxy)ethane thioacetate in
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Figure A.4.
CD2Cl2.

1

H NMR spectrum of 2-(2-(2-iodoethoxy)ethoxy)ethane thioacetate in
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Figure A.5.
CD2Cl2.

13

C NMR spectrum of 2-(2-(2-iodoethoxy)ethoxy)ethane thioacetate in
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Figure A.6. 1H NMR spectrum of 2-(2-(2-iodoethoxy)ethoxy)ethane thiol in CD2Cl2.
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Figure A.7. 13C NMR spectrum of 2-(2-(2-iodoethoxy)ethoxy)ethane thiol in CD2Cl2.

Scheme A.8. Synthesis of PNAlG-r-PNMG Copolymer: Benzylamine-initiated ROP of
Al-NCA and Me-NCA in acetonitrile at 50 oC.
Under inert conditions Al-NCA and Me-NCA were dissolved in anhydrous organic
solvents and a measured volume of benzyl amine/THF initiator stock solution was
added and allowed to stir at 50 ˚C for approximately 24 h (Scheme A.8). The amount of
Me-NCA and Al-NCA monomer used were predetermined in attempt to generate
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polymers with varied compositions. Copolypeptoids with PNAlG content as high as 47%
were obtained (Table A.9). The monomer conversion was monitored via FT-IR
spectroscopy. Copolymer precursors derived from the benzylamine initiated ROP of AlNCA and Me-NCA were properly characterized by 1H NMR spectroscopy (Table A.9).
The copolymer chain length was determined by the integration of methyl protons of
PNMG segments and terminal alkene proton of PNAlG segments side chains relative to
the aromatic protons of the benzyl end group in the 1H NMR spectrum (Figures A.9A.10).
Table A.9 Molecular composition of PNAlG-r-PNMG random copolymers.
[M1]o:[M2]o:[I]o a

DP (exp.) (1H NMR)

fPNAlG b

fPNMGb

45:5:1

PNMG39-r-PNAlG4

0.09

0.91

20:20:1

PNMG23-r-PNAlG20

0.47

0.53

a

Benzylamine-initiated ROP of Al-NCA and Me-NCA in acetonitrile at 50 oC.for 18-24 h;
b
Experimental molar fraction of each block in the random copolypeptoids determined via
1
H NMR spectroscopic analysis.
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Figure A.10 1H NMR spectra of PNAlG4-r-PNMeG39 random copolymer (red, top) and
the resulting polypeptoid obtained (blue, bottom) after radical thiol-ene addition of CPT
in CD3CN.

Figure A.11 1H NMR spectrum of cationic polypeptoid obtained by Sn2 substitution
reaction between PNAlG4-r-PNMeG39-CPT with trimethyl phosphine in CD3CN.
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Figure A.12. Normalized SEC chromatogram (0.1 M LiBr/DMF, 25 ○C) of the P(NPgG39r-NDeG9) copolypeptoid synthesized via benzylamine-initiated ring-opening
copolymerization of Pg-NCA and De-NCA. Mn (5.6 kg/mol) and PDI (1.03) of the
copolymer were determined using polystyrene standards.
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Figure A.13. Representative 13C NMR spectrum of the poly(N-propargyl glycine)
homopolymer (PNPgG) in CD2Cl2. 13C NMR (100 MHz, CD2Cl2), δ ppm: 168.9
(−COCH2N−), 128.7−127.5 (C6H5−), 77.5 (−NCH2CC−), 73.0 (−NCH2CC−), 47.1
(C6H5CH2N−), 37.6 (−COCH2N−), 36.6 (−NCH2CC−).
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Figure A.14. 1H NMR spectrum of cationic azido compound 1 in D2O.

Figure A.15. 1H NMR spectrum of cationic azido compound 8 in D2O.
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Figure A.16. 1H NMR spectrum of cationic azido compound 10 in D2O.

Figure A.17. 1H NMR spectrum of cationic azido compound 7 in D2O.
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Scheme A.18. A general synthetic scheme of -azido-alkyl ammonium derivatives.

1:
Yield: 67%, yellow solid. 1H NMR (400 MHz, THF-d8), δ ppm:  =
3.51-3.48 (t, J= 6.40, 2 H), 3.45-3.41 (t, J= 8.40, 2 H), 3.14 (s, 9 H), 2.13-2.07 (quint, 2
H). 13C{1H} NMR (100 MHz, D2O), δ ppm: 64.1, 53.2, 47.8, 22.4.

2:
Yield: 83%, yellow solid. 1H NMR (D2O):  = 3.58-3.55 (t, J= 6.40
Hz, 2 H), 3.32-3.28 (t, J= 7.88, 2 H), 2.97 (s, 6 H), 2.11-2.04 (quint, 2 H). 13C{1H} NMR
(100 MHz, D2O), δ ppm: 55.4, 48.1, 42.9, 23.6.

3:
Yield: ~100%, yellow solid. 1H NMR (D2O):  = 3.55-3.52 (t, J=
6.44 Hz, 2 H), 3.18-3.14 (t, J= 7.40 Hz, 2 H), 2.76 (s, 3 H), 2.01-1.98 (quint, 2 H).
13
C{1H} NMR (100 MHz, D2O), δ ppm: 48.2, 46.8, 32.9, 24.9.
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4:
Yield: 75%, yellow solid. 1H NMR (D2O): = 3.57 (t, J= 6.48, 2 H),
3.16-3.12 (t, J= 7.40, 2 H), 2.03-1.96 (quint, 2 H). 13C{1H} NMR (100 MHz, D2O), δ ppm:
48.3, 37.4, 26.1.

5:
Yield: 81%, yellow solid. 1H NMR (D2O):  = 3.46 (t, J= 6.52, 2
H), 2.78 (t, J= 4.75, 2 H), 1.56 (m, 2 H), 1.33 (quint, 2 H) 13C{1H} NMR (100 MHz, D2O),
δ ppm: 49.7, 38.3, 27.4, 24.9.

6:
Yield: 100%, yellow solid. 1H NMR (D2O):  = 3.40 (t, J= 6.79,
2 H), 3.06 (t, J= 4.80, 2 H), 1.75-1.67 (m, 4 H), 1.50 (quint, 2 H) 13C{1H } NMR (100
MHz, D2O), δ ppm: 50.9, 39.4, 27.5, 26.3, 22.9.

7:
Yield: 94%, yellow solid. 1H NMR (D2O):  = 3.39-3.36 (t, J=
6.40, 2 H), 3.05-3.02 (t, J= 6.40, 2 H), 1.66 (m, 4 H), 1.45 (quint, 4 H). 13C{1H } NMR
(100 MHz, D2O), δ ppm: 51.1, 39.4, 27.7, 26.6, 25.4, 25.1.
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Figure A.19. Representative 1H NMR spectrum of the poly(N-propargyl glycine-r-N-decyl
glycine) copolymer P(NPgG39-r-NDeG9) in CD2Cl2. The copolymer chain length was
determined by the integration of terminal methyl protons (l) of decyl side chains and
terminal alkyne proton (o) of propargyl side chains relative to the aromatic protons (a) of
the benzyl end group in the 1H NMR spectrum. H NMR (400 MHz, CD2Cl2), δ ppm:
7.23−7.19 ppm (br m, −C6H5, Ha), 4.43−4.15 ppm (br m, Pg/De−COCH2N−,
CHCCH2N−, Hb, Hm, Hn), 3.26 ppm (br m, CH3(CH2)8CH2N−, Hc), 2.43−2.28 ppm (br
m, CH CCH2−, Ho), 1.63−1.50 ppm (br m, CH3 (CH2) 6 (CH2 )2CH2N−, Hd, He), 1.37
ppm (br d, C H3(CH 2 ) 5C H 2 (CH 2 ) 3 N −, Hf), 1.18 ppm (br s, CH3(CH2)5(CH2)4N−,
Hg, Hh, Hi, Hj, Hk), 0.79 ppm (br s, CH3CH2(CH2)8N−, Hl).
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Figure A.20. Representative 13C NMR spectrum of the poly(N-propargyl glycine-r-Ndecyl glycine) copolymer P(NPgG39-r-NDeG9) in CD2Cl2. 13C NMR (100 MHz, CD2Cl2),
δ ppm: 168.9 (Pg/De−COCH2N−), 127.6 (−C6H5), 78.1 (−CHCCH2−), 73.3
(−CHCCH2−), 48.5 (CH3(CH2)8CH2N−), 47.3 (Pg/De− NCOCH2−), 37.7 (C6H5CH2N−),
36.6
(CH3(CH2)7CH2CH2N−),
31.8
(Pg−CCH2N−),
29.6
and
29.3
(CH3(CH2)3(CH2)4(CH2)2N−), 27.4 and 26.9 (CH3CH2(CH2)2(CH2)6N−), 22.6
(CH3CH2(CH2)7CH2N−), 13.8 (CH3(CH2)8CH2N−).
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Figure A.21. Representative 1H NMR spectrum of P1 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.17 (br. m,
−C=CHN−, Hd), 7.20 (br. m, −C6H5, Ha), 4.58-4.34 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.65 (s, −NCH2(CH2)2N(CH3)3, He), 3.41 (br. s, −N(CH2)3CH2N(CH3)3, Hg), 3.14
(br. s, −N(CH3)3, Hh); 2.49 (br. s, −NCH2CH2CH2N(CH3)3, Hf).
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Figure A.22. Representative 1H NMR spectrum of P2 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.04 (br. m,
−C=CHN−, Hd), 7.20 (br. m, −C6H5, Ha), 4.57-4.32 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.63 (s, −NCH2(CH2)2N(CH3)2, He), 3.25 (br. s, −N(CH2)2CH2N(CH3)2, Hg), 2.75
(−N(CH2)3N(CH3)2−, Hh), 2.47 (br. s, −NCH2CH2CH2N(CH3)2, Hf).
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Figure A.23. Representative 1H NMR spectrum of P3 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.15 (br. m,
−C=CHN−, Hd), 7.20 (br. m, −C6H5, Ha), 4.56-4.31 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.63 (s, −NCH2(CH2)2NCH3, He), 3.08 (br. s, −N(CH2)2CH2NCH3−, Hg), 2.72 (br. s,
−N(CH2)3NCH3, Hh), 2.34 (br. s, −NCH2CH2CH2NCH3, Hf).
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Figure A.24. Representative 1H NMR spectrum of P4 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.10-7.98 (br. m,
−C=CHN−, Hd), 7.20 (br. m, −C6H5, Ha), 4.61- 4.30 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.43 (s, −NCH2(CH2)2NH3, He), 2.98 (br. s, −N(CH2)2CH2NH3, Hg), 2.29 (br. s,
−NCH2CH2CH2NH3, Hf).

173

Figure A.25. Representative 1H NMR spectrum of P5 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.10-7.98 (br. m,
−C=CHN−, Hd), 7.20 (br. m, −C6H5, Ha), 4.61-4.30 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.43 (s, −NCH2(CH2)2NH3, He), 2.98 (br. s, −N(CH2)2CH2NH3, Hg), 2.29 (br. s,
−NCH2CH2CH2NH3, Hf).
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Figure A.26. Representative 1H NMR spectrum of P6 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.10-7.98 (br. m,
−C=CHN−−, Hd), 7.20 (br. m, −C6H5, Ha), 4.61-4.30 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.43 (s, −NCH2(CH2)2NH3, He), 2.98 (br. s, −N(CH2)2CH2NH3, Hg), 2.29 (br. s,
−NCH2CH2CH2NH3, Hf).
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Figure A.27. Representative 1H NMR spectrum of P7 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.10-7.98 (br. m,
−C=CHN−, Hd), 7.20 (br. m, −C6H5, Ha), 4.61-4.30 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.43 (s, −NCH2(CH2)2NH3, He), 2.98 (br. s, −N(CH2)2CH2NH3, Hg), 2.29 (br. s,
−NCH2CH2CH2NH3, Hf).
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Figure A.28. Representative 1H NMR spectrum of P8 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.10 (br. m,
−C=CHN−, Hd), 7.20 (br. m, −C6H5, Ha), 4.66-4.30 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.62 (s, −NCH2(CH2)3NH3, He), 3.04 (br. m, −N(CH2)3CH2NH3, Hh), 1.98 (br. s,
−NCH2CH2(CH2)2NH3, Hf), 1.66 (br. s, −N(CH2)2CH2CH2NH3, Hg).
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Figure A.29. Representative 1H NMR spectrum of P9 in D2O. Mn was determined by the
integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl end
group in the 1HNMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.12 (br. m,
−C=CHN−, Ha), 7.18 (br. m, −C6H5, Ha), 4.39 (br. m, −COCH2N−, −CCH2N−, Hb, Hc),
3.65 (s, −NCH2(CH2)4NH3, He), 3.02 (br. s, −N(CH2)4CH2NH3, Hi), 1.90 (br. s,
−N(CH2)3CH2CH2NH3, Hh); 1.68 (br. s, −NCH2CH2(CH2)3NH3, Hf); 1.33 (br. s,
−N(CH2)2CH2(CH2)2NH3, Hg).
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Figure A.30. Representative 1H NMR spectrum of P10 in D2O. Mn was determined by
the integration of the triazole proton (d) relative to the aromatic protons (a) of the benzyl
end group in the 1H NMR spectrum. 1H NMR (400 MHz, D2O), δ ppm: 8.01 (br. m,
−C=CHN−, Hd), 7.22 (br. m, −C6H5, Ha), 4.53-4.33 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.58 (s, −NCH2(CH2)5NH3, Hb, Hc), 2.98 (br. s, −N(CH2)5CH2NH3, Hj), 1.82 (br. s,
−NCH2CH2(CH2)4NH3, Hf), 1.62 (br. s, −N(CH2)4CH2CH2NH3, Hi); 1.34 (br. s,
−N(CH2)2CH2(CH2)3NH3, Hg), 1.25 (br. s, −N(CH2)3CH2(CH2)2NH3, Hh).
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Figure A.31. Representative 1H NMR spectrum of P11 in D2O. Mn of the charged
polymer portion was determined by the integration of the triazole proton (d) relative to
the aromatic protons (a) of the benzyl end group in the 1H NMR spectrum. Mn of the
uncharged polymer portion was determined by the integration of the methyl protons (l)
relative to the aromatic protons (a) of the benzyl end group in the 1H NMR spectrum. 1H
NMR (400 MHz, D2O), δ ppm: 8.10-8.01 (br. m, −C=CHN−, Ho), 7.32-7.21 (br. m,
−C6H5, Ha), 4.55-4.33 (br. m, −COCH2N−, −CCH2N−, Hb, Hm, Hn), 3.46 (s,
−NCH2(CH2)5NH3, Hp), 3.04 [br. s, (−NCH2(CH2)8CH3, −N(CH2CH2)(CH2)7CH3),
−NCH2CH2(CH2)4NH3, −N(CH2)5CH2NH3), Hc, Hd, Hq, Hu], 2.31 [br. s,
(−N(CH2)2CH2(CH2)3NH3, −N(CH2)2 (CH2CH2)(CH2)2NH3, −N(CH2)4CH2CH2NH3), Hr-Ht],
1.22 (br. m, −N(CH2)2(CH2)7CH3, He-Hk), 0.70-0.79 (br. m, −NCH2(CH2)8CH3, Hl).
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Figure A.32. Transfection efficiencies of polyplexes at various polypeptoid/DNA weight
ratios in B16F10 (A) and COS-7 (B) cells in the presence of 10% serum, and in HeLa
cells (C) under different serum conditions (n = 3). PEI in the presence of 30% serum in
HeLa cells (C).
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A.33 Experimental
A.34 General Considerations
All chemicals used were purchased from Sigma-Aldrich and used as received
unless otherwise noted. THF (Tetrahydrofuran) and DMF (Dimethyl Formamide) used
for polymerization and click reactions were purified by passing through alumina columns
under argon. All other solvents used in this study were purchased from Sigma without
further purification. N-propargyl N-carboxy anhydride (Pg-NCA) and N-decyl N-carboxy
anhydride (De-NCA) were synthesized by following a reported procedure.38 Poly(Npropargyl glycine) homopolymer (PNPgG) were synthesized by adapting a literature
procedure.39 All -azido alkyl ammonium compounds used in the synthesis of cationic
polypeptoids were prepared by adapting previous literature procedures.40-42
1

H and

13

C NMR spectra were recorded on Bruker AV-400 and AVIII-400

spectrometers, respectively. The peaks were referenced in parts per million (ppm)
relative to proton impurities of deuterated solvents (e.g., D2O). Size-exclusion
chromatography (SEC) was recorded on an Agilent 1200 system (Agilent 1200 series
degasser, isocratic pump, auto sampler and column heater) equipped with three
Phenomenex 5 μm, 300 × 7.8 mm columns, a Wyatt OptilabrEX differential refractive
index (DRI) detector with a 690 nm light source, and a Wyatt DAWN EOS multiangle
light scattering (MALS) detector (GaAs 30mW laser at  = 690 nm). DMF with 0.1 M
LiBr was used as the eluent at a flow rate of 0.5 mL/min. The temperature of the column
and detector was set at 25 C.46 All data analysis was performed using Wyatt Astra V
6.0 software. Mn and the molecular weight distribution index (PDI) of PNPgG were
obtained using a dn/dc of 0.1012 ± 0.0007 g/mol. Copper content was measured on
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Varian SpectrAA 220 Atomic Absorption Spectrometer. The flame absorption
spectrometry method was used with acetylene/air, lamp current of 4 mA, and slit width
of 0.5 nm.
A.35. Monomer Synthesis
All the monomers used in this work were synthesized by adapting reported
procedures.22 N-alkyl N-carboxyanhydrides (R-NCAs) with propargyl and decyl side
chains were synthesized via synthetic routes as shown in Scheme 2.1.
A.36. Polymer Synthesis
All linear homopolypeptoids and random copolypeptoids were synthesized by
primary amine-initiated ring opening polymerization of the corresponding N-substituted
N-carboxyany-drides (R-NCAs) in a concerted manner. A representative procedure for
the synthesis of P11 was presented. Inside a glovebox, a predetermined volume of
BnNH2/THF stock solution (120 µL, 200 mM) was added to a THF solution of Pg-NCA
(350 mg, 2.52 mmol, 0.5 M). The reaction mixture was stirred at 50 °C for 18 h under a
nitrogen atmosphere. The conversion was determined by the FT-IR spectroscopic
analysis of an aliquot of the reaction mixture. The final polymer was isolated by
precipitation into hexane and dried under vacuum at room temperature to yield the final
polymer as a white solid (230 mg, 96% yield). Mn and PDI of the polymer were
determined by SEC. PNPgG homopolymers with various number average degrees of
polymerization (DPn = 28-251) and low PDI were obtained (Table 3.1).

183

A.37. Representative
Homopolymers

Synthetic

Procedure

for

the

Cationic

Polypeptoid

Inside a glovebox, a measured amount of -azido hexyl ammonium salt (101 mg,
0.56 mmol) ([N3]0:[propargyl]0 = 2:1) was added into a DMF solution of the PNPgG
polymer (27.2 mg, 4 µmol, 0.28 mmol propargyl groups), followed by the addition of a
measured

volume

of

DMF

solution

of

CuBr/PMDETA

(250

mM,

564

µL,

[Cu]0:[PMDETA]0:[propargyl]0 = 33:33:100). The reaction mixture was stirred at 50 °C for
18 h. Upon addition of an aqueous solution of EDTA (9.9 mM, 3 mL), the reaction
mixture was then dialyzed against deionized (DI) water water for 24-48 h during which
the DI water was changed twice a day. The reaction mixture was then lyophilized to
yield a light greenish blue powder (70 mg, 91% yield).
A.38. Representative Synthetic Procedure for the Cationic Polypeptoid Copolymer
Inside a glovebox, a measured amount of -azido hexyl ammonium salt (82 mg,
0.46 mmol, [N3]0:[propargyl]0 = 2:1) was added into a DMF solution of P(NPgG39-rNDeG9) (33 mg, 6 µmol, 0.23 mmol propargyl groups), followed by the addition of a
measured

volume

of

DMF

solution

of

CuBr/PMDETA

(250

mM,

460

µL

[Cu]0:[PMDETA]0:[propargyl]0 = 33:33:100). The reaction mixture was stirred at 50 °C for
18 h. Upon addition of an aqueous solution of EDTA (9.9 mM, 3 mL), the reaction
mixture was dialyzed against the DI water for 24-48 h during which the DI water was
changed twice a day. The reaction mixture was then lyophilized to yield a light green
powder (85 mg, 91% yield).
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A.39. Determination of Copper Ion Content in the Cationic Polymers by Flame
Atomic Absorption Spectrometry (FAAS)
Cationic polypeptoids (10 mg) were dissolved in DI water (10 mL) at room
temperature, and the solution was analyzed by FAAS. The copper ion content was
determined by using the copper (II) absorption at 324.8 nm against a calibration curve
constructed using a CuSO4 standard.
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B.1. Experimental Section
B.2 Representative Procedure for PNPgG
Inside a glovebox, a fixed volume of BnNH2/THF stock solution (392 L, 200 mM)
was added a THF solution of Pg-NCA (545 mg, 3.92 mmol, 0.5 M). The reaction mixture
stirred at 50 °C under a nitrogen atmosphere for 18 h. The conversion was monitored by
the FT-IR spectroscopic analysis of an aliquot of the reaction mixture. Isolation of the
final polymer was achieved by precipitation into hexane then dried under vacuum at
room temperature to yield a white solid (300 mg, 80% yield). Mn and PDI of the final
polymer was determined by SEC. PNPgG homopolymers with various number average
degrees of polymerization (DP = 28-90) and low polydispersity indices (PDI) were
obtained (Table 4.1).
B.3. Representative Synthetic Procedure for P(NPgG-r-NDeG)
Under nitrogen, a predetermined volume of BnNH2/THF stock solution (200 mM,
181 L) was added to a THF solution of Pg-NCA (202 mg, 1.45 mmol, 0.4 M) and DeNCA (88 mg, 0.363 mmol, 0.1 M). The reaction mixture was stirred at 50 °C for 24 h in a
glovebox. Monomer conversion was determined by FTIR analysis of an aliquot of the
reaction mixture. The final polymer was isolated by precipitation with excess hexane
and dried under vacuum at room temperature to yield the polymer as a white solid (180
mg, 86% yield). Determination of copolymer composition (Entry P5, Table 4.1) was
done by end-group analysis using 1H NMR spectroscopy. For instance, the integration
of terminal alkyne proton of propargyl sidechain at 2.36-2.87 ppm and the terminal
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methyl proton of the decyl sidechain at 0.83 ppm relative to the integration of the
aromatic protons of the benzyl end group at 7.28 ppm were used to determine the DP of
the PNPgG and PNDG segment accordingly. 1H NMR (400 MHz, CD2Cl2), δ ppm: 7.237.19 ppm (br. m, −C6H5, Ha), 4.43-4.15 ppm (br. m,

Pg/De

−COCH2N−, CHCCH2N−, Hb,

Hm, Hn), 3.26 ppm (br. m, CH3(CH2)8CH2N−, Hc), 2.43-2.28 ppm (br. m, CHCCH2−, Ho),
1.63-1.50 ppm (br.

m,

CH3(CH2)6(CH2)2CH2N−,

Hd,

He),

1.37 ppm (br. d,

CH3(CH2)5CH2(CH2)3N−, Hf), 1.18 ppm (br. s, CH3(CH2)5(CH2)4N−, Hg, Hh, Hi, Hj, Hk),
0.79 ppm (br. s, CH3CH2(CH2)8N−, Hl);

C{1H} NMR (100 MHz, CD2Cl2), δ ppm: 168.9

13

(Pg/De−COCH2N−), 127.6 (−C6H5), 78.1 (−CHCCH2−), 73.3 (−CHCCH2−), 48.5
(CH3(CH2)8CH2N−),

47.3

(Pg/De−NCOCH2−),

37.7

(C6H5CH2N−),

36.6

(CH3(CH2)7CH2CH2N−), 31.8 (Pg−CCH2N−), 29.6 and 29.3 (CH3(CH2)3(CH2)4(CH2)2N−),
27.4

and

26.9

(CH3CH2(CH2)2(CH2)6N−),

22.6

(CH3CH2(CH2)7CH2N−),

13.8

(CH3(CH2)8CH2N−).
B.4. Representative Synthetic Procedure for Polypeptoid Homopolymer (P1)
Inside a glovebox, a measured amount of -azido hexyl ammonium salt (51 mg,
0.286 mmol, [N3]0 : [propargyl]0 = 2:1) was combined with the PNPgG polymer (23 mg, 3
mol, 0.239 mmol propargyl groups) in a DMF solution, followed by the addition of a
measured

volume

of

DMF

solution

of

CuBr/PMDETA

(250

mM,

478

L,

[Cu]0:[PMDETA]0:[propargyl]0 = 33:33:100). The reaction mixture was stirred at 50 °C for
18 h. Upon addition of an aqueous solution of EDTA (9.9 mM, 3 mL), the reaction
mixture was then dialyzed against deionized water (DI) for 24-48 h during which the DI
water was changed twice a day. The reaction mixture was then lyophilized to yield a
light greenish blue powder (60 mg, 91% yield). 1H NMR (400 MHz, D2O), δ ppm: 8.01
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(br. m, −C=CHN−, Hd), 7.22 (br. m, −C6H5, Ha), 4.53-4.33 (br. m, −COCH2N−,
−CCH2N−, Hb, Hc), 3.58 (s, −NCH2(CH2)5NH3, Hb, Hc), 2.98 (br. s, −N(CH2)5CH2NH3,
Hj), 1.82 (br. s, −NCH2CH2(CH2)4NH3, Hf), 1.62 (br. s, −N(CH2)4CH2CH2NH3, Hi); 1.34
(br. s, −N(CH2)2CH2(CH2)3NH3, Hg), 1.25 (br. s, −N(CH2)3CH2(CH2)2NH3, Hh).
B.5. Representative Synthetic Procedure for Polypeptoid Homopolymers (G1-G3)
Using a glovebox, a measured amount of -azido hexyl guanidinium salt (96 mg,
0.363 mmol, [N3]0 : [propargyl]0 = 2:1) was added to a DMF solution containing the
PNPgG polymer (23.7 mg, 4 mol, 0.242 mmol propargyl groups), followed by the
addition of a calculated volume of DMF solution of CuBr/PMDETA (250 mM, 484 L,
[Cu]0:[PMDETA]0:[propargyl]0 = 33:33:100). The reaction mixture was allowed to stir at
50 °C for 18 h. An aqueous solution of EDTA (9.9 mM, 3 mL) was added to the reaction
mixture and then dialyzed against DI water for 24-48 h during which the DI water was
changed twice a day. The final reaction mixture was then lyophilized to yield a light
greenish blue powder (60 mg, 68% yield). 1H NMR (400 MHz, D2O), δ ppm: 8.01 (br. m,
−C=CHN−, Hd), 7.22 (br. m, −C6H5, Ha), 4.53-4.33 (br. m, −COCH2N−, −CCH2N−, Hb,
Hc), 3.58 (s, −NCH2(CH2)5C(NH)2NH2, He), 2.98 (br. s, −N(CH2)5CH2C(NH)2NH2, Hj),
1.82 (br. s, −NCH2CH2(CH2)4C(NH)2NH2, Hf), 1.62 (br. s, −N(CH2)4CH2CH2C(NH)2NH2,
Hi);

1.34

(br.

s,

−N(CH2)2CH2(CH2)3C(NH)2NH2,

Hg),

1.25

(br.

s,

−N(CH2)3CH2(CH2)2C(NH)2NH2, Hh).
B.6. Representative Synthetic Procedure for Polypeptoid Random Copolymer
(GD48)
In a glovebox, a fixed amount of -azido hexyl guanidinium salt (117 mg, 0.440
mmol, [N3]0: [propargyl]0 = 2:1) was added into a DMF solution of PNPG39-r-PNDG9
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(31.0 mg, 5 mol, 0.22 mmol propargyl groups), succeeded by the addition of a
measured

volume

of

CuBr/PMDETA

in

DMF

solution

(250

mM,

460

L

[Cu]0:[PMDETA]0:[propargyl]0= 33:33:100). The reaction mixture stirred for 18 h at 50
°C. Upon addition of an aqueous solution of EDTA (9.9 mM, 3 mL), the reaction mixture
was dialyzed for 24-48 h against DI water during which the DI water was changed twice
a day. The reaction mixture was then lyophilized to yield a light green powder (95 mg,
80% yield). 1H NMR (400 MHz, D2O), δ ppm: 8.10-8.01 (br. m, −C=CHN−, Ho), 7.327.21 (br. m, −C6H5, Ha), 4.55-4.33 (br. m, −COCH2N−, −CCH2N−, Hb, Hm, Hn), 3.46 (s,
−NCH2(CH2)5C(NH)2NH2, Hp), 3.04 [br. s, (−NCH2(CH2)8CH3, −N(CH2CH2)(CH2)7CH3),
−NCH2CH2(CH2)4C(NH)2NH2, −N(CH2)5CH2C(NH)2NH2, Hc, Hd, Hq, Hu], 2.31 [br. s,
(−N(CH2)2CH2(CH2)3C(NH)2NH2,

−N(CH2)2

(CH2CH2)(CH2)2C(NH)2NH2,

−N(CH2)4CH2CH2C(NH)2NH2), Hr-Ht], 1.22 (br. m, −N(CH2)2(CH2)7CH3, He-Hk), 0.700.79 (br. m, −NCH2(CH2)8CH3, Hi).
B.7. Determination of Copper Ion Content in the Polymers by Flame Atomic
Absorption Spectrometry (FAAS)
Polypeptoids (10 mg) were dissolved in deionized water at 1 mg mL-1. The solution
was analyzed by FAAS. The copper ion content was then determined by using the
copper (II) absorption at 324.8 nm against a calibration curve constructed using a
CuSO4 standard.
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Figure B.7. Representative 1H NMR spectrum of P54 in D2O.
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Figure B.8. Representative 1H NMR spectrum of G30 in D2O.

191

Figure B.9. Representative 1H NMR spectrum of G54 in D2O.
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Figure B.10. Representative 1H NMR spectrum of G103 in D2O.
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Figure B.11. TNF-α levels of RAW 264.7 cells following treatment with
polypeptoids/TNF-α siRNA polyplexes for 4 h at 0.2 μg/well siRNA in DMEM containing
10% FBS, incubation in fresh media for 20 h, and subsequent LPS stimulation at 100
ng/mL for 5 h (n = 3).
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Figure B.12. TNF-α levels of RAW 264.7 cells following treatment with
polypeptoids/TNF-α siRNA polyplexes for 4 h at 0.2 μg/well siRNA in DMEM containing
10% FBS, incubation in fresh media for 20 h, and subsequent LPS stimulation at 100
ng/mL for 5 h (n = 3).
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Figure B.13. TNF-α levels of RAW 264.7 cells following treatment with
polypeptoids/TNF-α siRNA polyplexes for 4 h at 0.2 μg/well siRNA in DMEM containing
10% FBS, incubation in fresh media for 20 h, and subsequent LPS stimulation at 100
ng/mL for 5 h (n = 3).
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Figure B.14. Systemically administered G4/TNF-α siRNA polyplexes mediate antiinflammatory effect against LPS/D-GalN-induced hepatic failure: serum ALT and AST
levels.
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C
A

B

Figure C.1. 1H NMR spectrum of XAA in CDCl3.
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Figure C.2. 1H NMR spectrum of N-ethoxythiocarbonyl-N-allylglycine (N-Al-XAA) in
CDCl3.
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Figure C.3. High resolution ESI-MS of N-Allyl NTA monomer.
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C.4. FT-IR spectra
of@4h.0
Al-NCA
monomer
over time (in neat).
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C.5. FT-IR spectra
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Figure C.6. Plot of Mn versus [M]0:[I]0 and PDI for the BnNH2 mediated ROP
of Allyl NTA in THF at 60 ᵒC.

Figure C.7. Plot of Mn versus [M]0:[I]0 and PDI for the BnNH2 mediated ROP
of Allyl NTA in THF at 50 ᵒC.
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Figure C.8. 1H NMR spectra of Benzylamine mediated iROPs with Al-NTA at 90 ⁰C in
CDCN3 (M0:I0= 25-400). Final polymer chain length cannot be accurately determined by
end-group analysis method due to severe overlap of monomer and polymer peaks.
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